Prerpints.org logo
Preprint
Review

Bioactive Calcium Phosphate Coatings for Bone Implant Applications: A Review

Altmetrics

Downloads

287

Views

429

Comments

0

A peer-reviewed article of this preprint also exists.

Submitted:

11 May 2023

Posted:

11 May 2023

You are already at the latest version

Alerts
Abstract
This review article deals with the design of bioactive calcium phosphate coatings deposited on metallic substrates to produce bone implants. The bioceramic coating properties are used to create a strong bonding between the bone implants and the surrounding bone tissue. They provide a fast response after implantation and increase the lifespan of the implant in the body environment. The first part of the article describes the different compounds belonging to the calcium phosphate family and their main properties for applications in biomaterials science. The calcium to phosphorus atomic ratio (Ca/P)at. and the solubility (Ks) of these compounds define their behavior in a physiological environment. Hydroxyapatite is the gold standard among calcium phosphate materials, but other chemical compositions/stoichiometries have also been studied for their interesting properties. The second part reviews the most usual deposition processes to produce bioactive calcium phosphate coatings for bone implant applications. Plasma spraying is the main industrial process, but magnetron sputtering, pulsed laser deposition, electrospray deposition, electrophoretic deposition, and electrodeposition are also widely studied in academic and industrial research. The last part describes the main physicochemical properties of calcium phosphate coatings and their impact on the bioactivity of bone implants in a physiological environment.
Keywords: 
Subject: Chemistry and Materials Science  -   Biomaterials

1. Introduction

The ageing of the world population induces an increasing clinical demand for skeletal repair [1,2,3,4,5,6]. In particular, orthopedic and dental surgeries require metallic bone implants made of titanium alloys [7,8,9,10,11,12,13,14,15,16], iron-based alloys and stainless steel [17,18,19,20,21], or CoCr alloys [22,23,24,25,26,27,28]. The mechanical properties of these alloys are appropriate for load-bearing applications, and they are biocompatible with the body environment. According to the International Union of Pure and Applied Chemistry (IUPAC), biocompatibility is the ability of a material to be in contact with a biological system without producing an adverse effect [29,30,31,32,33,34]. Surface modification of these metallic bone implants with a coating is however necessary to make them bioactive in the body environment. Bioactivity is the property of materials to develop a direct, adherent, and strong bonding with the bone tissue [35,36,37,38,39,40]. Among the bioactive materials, calcium phosphates are the most usual in industry and academic research. They are ceramic materials with a chemical composition like that of bone mineral, the inorganic component of our bones [41,42,43,44,45,46,47]. Inside the body, their bioactivity confers long-term stability to the metallic bone implant. They prevent bone anchorage failure and delay revision surgery [48,49,50,51,52]. Several methods can be used to produce calcium phosphate coatings on metallic bone implants such as plasma spraying, magnetron sputtering, pulsed laser deposition, electrospray deposition, electrophoretic deposition, and electrodeposition [53]. Among them, plasma spraying is the main industrial process, extensively used since the 1970s to coat metallic bone implants [54]. Other deposition processes have been developed for decades, and their advantages and drawbacks are nowadays well-established. The properties of a calcium phosphate coating depend on the process used to produce it, and on the experimental conditions and deposition parameters as well. They are of great importance because the modification of the coating properties may influence the surface bioactivity of the bone implant in a physiological environment.
After a presentation of the bioceramic compounds belonging to the calcium phosphate family, this review article describes the main deposition methods used to produce calcium phosphate coatings. The specific coating properties associated with each deposition process are reviewed. The last part describes the way the physicochemical properties of calcium phosphate coatings influence the bioactivity of the bone implant inside the body.

2. Calcium Phosphates

Calcium phosphate bioceramics are materials made of calcium ions ( C a 2 + ) and phosphate ions ( H 2 P O 4 − , H P O 4 2 − , or P O 4 3 − ). Several compounds belong to this family, with different stoichiometries and different phosphate species. They are specifically identified in biomaterials science by their calcium to phosphorus atomic ratio (Ca/P)at. (Table 1).
The stoichiometry of a calcium phosphate coating affects its solubility in a physiological environment which is the first step involved in the bioactivity process after implantation (Figure 1).
The partial dissolution of the calcium phosphate coating in contact with the physiological environment induces ionic releases. The local concentrations of calcium and phosphate ions increase up to supersaturation which triggers the precipitation of biological apatite at the interface between the implant and the surrounding bone tissues [30,31,35,36,37,38]. After these first chemical steps, the biological steps start, involving bone cell attachment, proliferation, and differentiation. In the last step of the bioactivity process, the bone cells trigger the formation of the extracellular matrix (ECM) which is a three-dimensional network of macromolecules and minerals, such as collagen, enzymes, glycoproteins, and apatite [88,89,90]. The function of the extracellular matrix is to provide structural and biochemical support to the surrounding bone cells to promote their development [91]. Due to the bioactivity of the calcium phosphate coatings, bone-like apatite is formed at the interface between the bone implant and the bone tissue. This bone-like apatite layer is a direct, adherent, and strong bonding that results in the long-term stability of the bone implant inside the human body [92]. However, the success of the bioactivity process is related to several properties of the calcium phosphate coating and not only to the stoichiometry and solubility of the bioceramic material. The choice of the process and the experimental deposition conditions may influence many physicochemical properties of the calcium phosphate coating, and consequently the bioactivity process.

3. Deposition Methods

3.1. Plasma Spraying (PS)

Plasma spraying is the most widespread industrial process because it is remarkably efficient at producing large quantities of bioceramic coatings on metallic bone implants with good reproducibility. A calcium phosphate powder (generally hydroxyapatite) is injected into a plasma jet the temperature of which is thousands of degrees [93,94]. At this high temperature, the grains of powder are molten or partly molten. The plasma jet directs the molten powder toward the bone implant surface where the steps of accumulation, cooling down, and solidification produce a coating (Figure 2).
However, the high temperatures of the process result in several issues. The calcium phosphate particles melt incongruently, locally resulting in structural modifications, uncontrolled phase changes, and chemical decompositions. These modifications produce a coating whose physicochemical and biological properties differ from those of the initial powder [96,97,98]. The thermal decomposition of hydroxyapatite within a plasma is comprehensively described by Heimann’s works from the following reactions [99]:
C a 10 P O 4 6 O H 2 → C a 10 P O 4 6 O H 2 − 2 x O x ⬚ x + x H 2 O (1)
C a 10 P O 4 6 O H 2 − x O x ⬚ x → C a 10 P O 4 6 O x ⬚ x + 1 − x H 2 O (2)
C a 10 P O 4 6 O x ⬚ x → 2 C a 3 P O 4 2 + C a 4 O P O 4 2 (3)
C a 3 P O 4 2 → 3 C a O + P 2 O 5 (4)
C a 4 O P O 4 2 → 4 C a O + P 2 O 5 (5)
As a function of the experimental parameters, these five reactions may occur during plasma spray deposition, where ⬚ x refers to lattice vacancies in the crystal structure of the calcium phosphate compound. The resulting bioceramic coating contains a mixture of oxyhydroxyapatite ( C a 10 P O 4 6 O H 2 − 2 x O x ⬚ x ), oxyapatite ( C a 10 P O 4 6 O x ⬚ x ), tricalcium phosphate ( C a 3 P O 4 2 ), tetracalcium phosphate ( C a 4 O P O 4 2 ), phosphorous pentoxide ( P 2 O 5 ), and calcium oxide ( C a O ) instead of pure hydroxyapatite as initially expected. All these additional phases affect the physicochemical properties of the coatings. Moreover, plasma spray deposition produces coatings with interconnected pores and cracks caused by imperfect melting of the particles, the insufficient flow of molten droplets in contact with the substrate, rapid solidification rate, and poor interlayer bonding [100,101]. The high temperature of the plasma induces a local melt-quenching of the particles that results in the amorphization of the bioceramics. The control of the chemical composition and structural properties of plasma sprayed calcium phosphate coatings is difficult. They are made of several phases in several crystalline states, resulting in a highly heterogeneous bioactive behavior in a physiological environment. Nonetheless, the process is efficient to reach industrial objectives, i.e., the production of large quantities of coatings at a low cost. The mechanical properties of the coatings are also satisfying, especially their hardness and long-term stability in normal storage conditions. The adhesion to the metallic substrate is generally high enough, even if many research works are still trying to find solutions to improve it more [102]. Adhesion is a key property of industrial calcium phosphate coatings whose value is standardized for the biomedical market (see section 4.5.).
Because plasma spraying has advantages and drawbacks, the study of alternative processes to produce calcium phosphate coatings for bone implant applications remains a major research topic for academic and industrial biomedical research.

3.2. Magnetron Sputerring (MS)

Magnetron sputtering of a calcium phosphate target is an alternative solution to produce bioactive calcium phosphate coatings on bone implants. Magnetron sputtering is a physical vapor deposition (PVD) process. A deposition chamber at room temperature is evacuated to high vacuum to remove all potential contaminants. After the base pressure has been reached, a working gas is injected inside the chamber, usually a noble gas such as argon. The resulting pressure is typically around 1 Pa. Plasma is then ignited from this noble gas by applying a voltage between the cathode connected to the target and the anode connected to the deposition chamber as electrical ground (Figure 3). The voltage necessary to start a discharge in a gas between two electrodes as a function of pressure and gap length is given by Paschen’s law [103,104]. The process requires plasma ignition and a self-sustained discharge. Plasma contains high-energy ions that collide with the atoms of the target with enough energy to eject and transport them toward the surface of the bone implant to progressively form a coating [105].
Direct current (DC) magnetron sputtering cannot be used to sputter insulating materials such as bioceramics because of the charge accumulation within the target during the process. Pulsed-DC or radio frequency (RF) magnetron sputtering are alternative solutions to deposit insulating materials [106,107,108]. They produce dense, uniform, and adherent calcium phosphate coatings. However, the different elements of a multicomponent target have different sputtering behaviors. The elemental stoichiometry of the deposited coating usually differs from that of the target. The experimental parameters of the process can be used to modify some properties of the deposited calcium phosphate coatings such as stoichiometry, morphology, and structure, resulting in different bioactive behaviors [109,110,111].

3.3. Pulsed Laser Deposition (PLD)

Pulsed laser deposition is another PVD process carried out in a vacuum chamber [112,113,114]. The ablation of a calcium phosphate target hit by a high-power laser produces a plasma plume made of ejected atoms, ions, and electrons (Figure 4). In contact with the substrate, the ejected material nucleates and grows to form a surface coating.
The efficiency of the process mainly depends on the laser properties such as wavelength, energy density, fluence, and pulse width. Pulsed laser deposition produces uniform and adherent thin coatings at a high deposition rate. However, as observed for magnetron sputtering, the elemental stoichiometry of the target and that of the deposited coating are not the same. The physicochemical and biological properties of the coating are impacted by the experimental conditions of the process [116,117,118].

3.4. Electrospray Deposition (ESD)

Electrospray deposition requires a precursor solution containing calcium and phosphate ions, or a suspension of calcium phosphate particles. The solution is sprayed by using a syringe through a nozzle that is connected to high voltage (Figure 5).
The droplets coming out of the tip of the nozzle are electrically charged. They travel toward the bone implant surface that is grounded and heated. In contact with the substrate, the droplets lose their surface charge and dry, progressively producing the bioactive coating (Figure 6).
The morphological and structural properties of the coatings are impacted by the process parameters [120,121,122,123,124].

3.5. Electrophoretic Deposition (EPD)

Electrophoretic deposition occurs by the migration of calcium phosphate particles of a colloidal suspension [125,126,127]. In a solution, typically water or ethanol, the calcium phosphate particles carry a positive or negative surface charge due to electrostatic interactions with the ionic species of the solution. This surface charge induces the formation of a diffuse double layer containing anions and cations (Figure 7).
The potential difference between the solution and the interface of the two layers is called zeta potential (ζ). This surface potential impacts the stability of colloidal dispersions by inducing electrostatic interactions between the particles of the suspension [128,129,130,131,132,133,134]. Thanks to zeta potential, the particles can be set in motion in the solution under the influence of an electric field between two conductive electrodes connected to a generator. If the particles are positively charged, they move through the liquid toward the cathode (cathodic EPD in Figure 8a). If the particles are negatively charged, they move toward the anode (anodic EPD in Figure 8b).
When a particle reaches the surface of an electrode, the size of the double layer is reduced (Figure 9a), promoting the progressive accumulation and coagulation of particles to form a calcium phosphate coating (Figure 9b).
The main parameters for the success of the EPD process are the pH and the stability of the suspension, the dielectric constant (ε) and the viscosity (η) of the solvent, the average particle size, the substrate conductivity, the voltage, the distance between the electrodes, and the deposition time. Post-deposition thermal annealing is required to evaporate the solvent and to improve the cohesive and adhesive properties of the coating [135,136].

3.6. Electrodeposition (ELD)

Electrodeposition of calcium phosphate coatings requires two electrodes immersed in an electrolytic solution of calcium and phosphate ions. They are connected to a generator. The cathode is the negative electrode, and the anode is the positive electrode (Figure 10) [137,138,139,140,141,142].
Electrochemical reactions occur at both electrode-electrolyte interfaces. The reduction of water, the solvent of the solution, takes place at the cathode surface as follows:
2 H 2 O   +   2 e − → H 2 ↑   +   2 O H −
If the solution is acidic, the reduction of protons may also occur at the cathode surface:
2 H +   +   2 e − → H 2 ↑
The resulting local pH variation triggers the precipitation of a calcium phosphate coating (Figure 11) [143,144,145,146,147,148].
The chemical composition and the stoichiometry of the precipitated coating depend on the pH value at the cathode which is impacted by the process parameters. The following phases can be obtained:
- dicalcium phosphate dihydrate (brushite):
C a 2 +   +   H P O 4 2 −   +   2 H 2 O   →   C a H P O 4 · 2 H 2 O
- octacalcium phosphate:
8 C a 2 +   +   2 H P O 4 2 −   +   4 P O 4 3 −   +   5 H 2 O   →   C a 8 ( H P O 4 ) 2 ( P O 4 ) 4 · 5 H 2 O
- calcium-deficient apatite:
( 10 − x ) C a 2 +   +   x H P O 4 2 −   +   ( 6 − x ) P O 4 3 −   +   ( 2 − x ) O H −   →   C a 10 − x ( H P O 4 ) x ( P O 4 ) 6 − x ( O H ) 2 − x
with 0 < x < 2
- hydroxyapatite:
10 C a 2 +   +   6 P O 4 3 −   +   2 O H −   →   C a 10 ( P O 4 ) 6 ( O H ) 2
The first experiments typically used direct current but pulsed current electrodeposition became more usual in the most recent years. The break times are used to reduce the negative effect of H2 bubbles and to homogenize the electrolyte concentrations [149,150,151,152,153]. Ionic substitution of the electrodeposited calcium phosphate coating can be easily obtained by modifying the electrolyte composition. Due to the low temperature of the process, the addition of organic components (polymers, proteins, drugs, etc.) is also possible to improve the biological and mechanical performances of the electrodeposited coating [154,155,156].

4. Main Properties Impacting the Bioactivity of Calcium Phosphate Coatings

In addition to stoichiometry and solubility, several physicochemical properties impact the bioactivity of calcium phosphate coatings immersed in a physiological environment. Crystallinity, morphology, roughness, wettability, adhesion, and ionic substitution are the most important ones.

4.1. Crystallinity

The crystallinity of calcium phosphate coatings impacts their solubility in a physiological environment. The more crystallized, the more stable the coating is in solution [157,158,159]. Crystallinity can be controlled by post-deposition thermal annealing. The international standard ISO 13779-2 recommends a degree of crystallinity higher than 45 % for the biomedical market of bone implants [160]. However, as a function of the annealing temperature, several phases can form in addition to the calcium phosphate phases [161,162]. To maintain a low level of toxicity, the quantity of secondary phases (for example CaO) in the calcium phosphate coatings must be less than 5 wt.% [160]. The methods to determine the crystallinity of calcium phosphate coatings and the quantity of secondary phases are comprehensively detailed in the international standard ISO 13779-3 [163].

4.2. Morphology

The surface morphology of calcium phosphate coatings impacts the bone cells’ attachment, growth, proliferation, and differentiation [164,165]. As a function of the deposition process and the experimental conditions, the surface morphology of the coatings can change [166,167]. Smooth surfaces are more efficient for bone cells attachment than sharp morphologies [168]. According to Cairns et al., a regular smooth topography significantly promotes osteocalcin expression and alkaline phosphatase activity in comparison with sharp surfaces made of needles [169]. Osteocalcin and alkaline phosphatase are growth factors involved in the bone formation process by supporting bone cell growth [170].

4.3. Roughness

Bioactivity is a surface phenomenon impacted by the roughness of materials. High roughness of more than 2 µm is not appropriate because the long distances between valleys and peaks prevent the formation of osteoblastic pseudopodia required for bone cell adhesion [171,172,173]. Calcium phosphate coatings with roughness values in the range of 0.5 to 1 μm are generally described to be the most interesting to promote bone cell activity [174,175,176].

4.4. Wettability

Surface wettability is a key property of calcium phosphate coatings because the bioactivity processes occur in a liquid medium. Contact angle (θ) measurements are used to quantify the wetting behavior of a drop of physiological solution deposited on the coating surface [177,178,179]. As a function of the contact angle value, the surface is qualified as hydrophilic or hydrophobic (Figure 12).
Biomaterials with hydrophilic surfaces are more interesting to promote chemical and biological interactions with the physiological environment [181,182].

4.5. Adhesion

Adhesion of calcium phosphate coatings is the main mechanical property for the biomedical market [102,183,184,185,186,187]. The value is determined by tensile adhesion measurements according to the international standard ISO 13779-4 [188].
The measurement requires a Ti6Al4V cylinder (25 mm in diameter and 25 mm in height) with one surface coated with calcium phosphate. The coated surface is pasted to another Ti6Al4V cylinder using adhesive glue (Figure 13a). The entire system is introduced inside a standard tensile machine where an increasing load is applied (Figure 13b) until the separation of the coating by breaking the interface with the initially coated cylinder (Figure 13c). Five measurements are necessary to obtain an average adhesion value. The bone implant industry requires adhesion values higher than 15 MPa [188].

4.6. Ionic Substitution for Biological Enhancement

The bioactivity and biological properties of calcium phosphate coatings can be improved by ionic substitution [189,190,191,192,193,194,195,196,197,198,199]. The objective is to release the substituting ions in the physiological environment after implantation, taking advantage of the dissolution process (see Section 2). Several ionic substitutions are described in the literature, using monovalent cations, divalent cations, trivalent cations, or anions. They are used for various biological or chemical effects described in Table 2.
A few percent of these ions are generally used to produce substituted calcium phosphate coatings. Multi-substitution with several substituting ions is also described in the literature with the objective to cumulate the positive effects on the biological properties of bone implants [267,268,269,270,271,272,273,274,275,276,277,278,279,280,281].

5. Conclusions

This article reviewed the calcium phosphate compounds that are used as coatings to make the surface of metallic bone implants bioactive. The link between stoichiometry, solubility, and bioactivity of calcium phosphate coatings was explained. The main processes used in industry and academic research to design calcium phosphate coatings were described. Plasma spraying is historically the first industrial process, but interesting alternative methods were also described. The stoichiometry and the physicochemical properties of the calcium phosphate coatings depend on the deposition process and the experimental conditions used to produce it. The impact of the properties of the coating on bioactivity was described. Finally, the ionic substitution of calcium phosphate coatings was reviewed from the literature, including the biological enhancements provided by the ionic substitution.

Author Contributions

Conceptualization, R.D., J.F. and H.B.; methodology, R.D., J.F. and H.B.; validation, R.D., J.F. and H.B.; investigation, R.D., J.F. and H.B.; resources, R.D., J.F. and H.B.; writing—original draft preparation, R.D., J.F. and H.B.; writing—review and editing, R.D., J.F. and H.B. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Available online: https://www.who.int/news-room/fact-sheets/detail/ageing-and-health (accessed on 10 May 2023).
  2. Demontiero, O.; Vidal, C.; Duque, G. Aging and bone loss: New insights for the clinician. Ther. Adv. Musculoskel. Dis. 2012, 4 (2), 61-76. [CrossRef]
  3. Gheno, R.; Cepparo, J.M.; Rosca, C.E.; Cotton, A. Musculoskeletal Disorders in the Elderly. J. Clin. Imaging Sci. 2012, 2 (3), 39. [CrossRef]
  4. U.S. Department of Health and Human Services. Bone Health and Osteoporosis: A Report of the Surgeon General. Rockville, U.S.A., 2004. PMID: 20945569.
  5. Li, G.; Thabane, L.; Papaioannou, A.; Ioannidis, G.; Levine, M.A.H.; Adachi, J.D. An overview of osteoporosis and frailty in the elderly. BMC Musculoskelet. Disord. 2017, 18, 46. [CrossRef]
  6. Bal, Z.; Kaito, T.; Korkusuz, F.; Yoshikawa, H. Bone regeneration with hydroxyapatite-based biomaterials. Emergent Mater. 2020, 3, 521-544. [CrossRef]
  7. Farrakhov, R.; Melnichuk, O.; Parfenov, E.; Mukaeva, V.; Raab, A.; Sheremetyev, V.; Zhukova, Y.; Prokoshkin, S. Comparison of Biocompatible Coatings Produced by Plasma Electrolytic Oxidation on cp-Ti and Ti-Zr-Nb Superelastic Alloy. Coatings 2021, 11, 401. [CrossRef]
  8. Ijaz, M.F.; Laillé, D.; Héraud, L.; Gordin, D.M.; Castany, P.; Gloriant, T. Design of a novel superelastic Ti-23Hf-3Mo-4Sn biomedical alloy combining low modulus, high strength and large recovery strain. Mater. Lett. 2016, 177, 39-41. [CrossRef]
  9. Sheremetyev, V.; Lukashevich, L.; Kreitcberg, A.; Kudryashova, A.; Tsaturyants, M.; Galkin, G.; Andreev, V.; Prokoshkin, S.; Brailovski, V. Optimization of a thermomechanical treatment of superelastic Ti-Zr-Nb alloys for the production of bar stock for orthopedic implants. J. Alloys Compd. 2022, 928, 167143. [CrossRef]
  10. Lukashevich, K.; Sheremetyev, V.; Komissarov, A.; Cheverikin, V.; Andreev, V.; Prokoshkin, S.; Brailovski, V. Effect of Cooling and Annealing Conditions on the Microstructure, Mechanical and Superelastic Behavior of a Rotary Forged Ti-18Zr-15Nb (at. %) Bar Stock for Spinal Implants. J. Funct. Biomater. 2022, 13 (4), 259. [CrossRef]
  11. He, G.; Hagiwara, M. Ti alloy design strategy for biomedical applications. Mater. Sci. Eng. C 2006, 26 (1), 14-19. [CrossRef]
  12. Geetha, M.; Singh, A.K.; Asokamani, R.; Gogia, A.K. Ti based biomaterials, the ultimate choice for orthopaedic implants - A review. Prog. Mater. Sci. 2009, 54 (3), 397-425. [CrossRef]
  13. Chen, Q.; Thouas, G.A. Metallic implant biomaterials. Mater. Sci. Eng. R 2015, 87, 1-57. [CrossRef]
  14. Sherif, E.S.M.; Bahri, Y.A.; Alharbi, H.F.; Ijaz, M.F.; Alnaser, I.A. Influence of Tantalum Addition on the Corrosion Passivation of Titanium-Zirconium Alloy in Simulated Body Fluid. Materials 2022, 15 (24), 8812. [CrossRef]
  15. Andreucci, C.A.; Alshaya, A.; Fonseca, E.M.M.; Jorge, R.N. Proposal for a New Bioactive Kinetic Screw in an Implant, Using a Numerical Model. Appl. Sci. 2022, 12, 779. [CrossRef]
  16. Chashmi, M.J.; Fathi, A.; Shirzad, M.; Jafari-Talookolaei, R.A.; Bodaghi, M.; Rabiee, S.M. Design and Analysis of Porous Functionally Graded Femoral Prostheses with Improved Stress Shielding. Designs 2020, 4, 12. [CrossRef]
  17. Drevet, R.; Zhukova, Y.; Malikova, P.; Dubinskiy, S.; Korotitskiy, A.; Pustov, Y.; Prokoshkin, S. Martensitic Transformations and Mechanical and Corrosion Properties of Fe-Mn-Si Alloys for Biodegradable Medical Implants. Metall. Mater. Trans. A 2018, 49 (3), 1006-1013. [CrossRef]
  18. Drevet, R.; Zhukova, Y.; Kadirov, P.; Dubinskiy, S.; Kazakbiev, A.; Pustov, Y.; Prokoshkin, S. Tunable corrosion behavior of calcium phosphate coated Fe-Mn-Si alloys for bone implant applications. Metall. Mater. Trans. A 2018, 49 (12), 6553-6560. [CrossRef]
  19. Prokoshkin, S.; Pustov, Y.; Zhukova, Y.; Kadirov, P.; Dubinskiy, S.; Sheremetyev, V.; Karavaeva, M. Effect of Thermomechanical Treatment on Functional Properties of Biodegradable Fe-30Mn-5Si Shape Memory Alloy. Metall. Mater. Trans. A 2021, 52, 2024–2032. [CrossRef]
  20. Koumya, Y.; Ait Salam, Y.; Khadiri, M.E.; Benzakour, J.; Romane, A.; Abouelfida, A.; Benyaich, A. Pitting corrosion behavior of SS-316L in simulated body fluid and electrochemically assisted deposition of hydroxyapatite coating. Chem. Pap. 2021, 75(6), 2667-2682. [CrossRef]
  21. Trincă, L.C.; Burtan, L.; Mareci, D.; Fernández-Pérez, B.M.; Stoleriu, I.; Stanciu, T.; Stanciu, S.; Solcan, C.; Izquierdo, J.; Souto, R.M. Evaluation of in vitro corrosion resistance and in vivo osseointegration properties of a FeMnSiCa alloy as potential degradable implant biomaterial. Mater. Sci. Eng. C 2021, 118, 111436. [CrossRef]
  22. Tchana Nkonta, D.V.; Simescu-Lazar, F.; Drevet, R.; Aaboubi, O.; Fauré, J.; Retraint, D.; Benhayoune, H. Influence of the surface mechanical attrition treatment (SMAT) on the corrosion behavior of Co28Cr6Mo alloy in Ringer’s solution. J. Solid State Electrochem. 2018, 22 (4), 1091-1098. [CrossRef]
  23. Chen, Y.; Li, Y.; Kurosu, S.; Yamanaka, K.; Tang, N.; Koizumi, Y.; Chiba, A. Effects of sigma phase and carbide on the wear behavior of CoCrMo alloys in Hanks’ solution. Wear 2014, 310 (1-2), 51-62. [CrossRef]
  24. Tchana Nkonta, D.V.; Drevet, R.; Fauré, J.; Benhayoune, H. Effect of surface mechanical attrition treatment on the microstructure of cobalt–chromium–molybdenum biomedical alloy. Microsc. Res. Tech. 2021, 84 (2), 238-245. [CrossRef]
  25. AlMangour, B.; Luqman, M.; Grzesiak, D.; Al-Harbi, H.; Ijaz, F. Effect of processing parameters on the microstructure and mechanical properties of Co–Cr–Mo alloy fabricated by selective laser melting. Mater. Sci. Eng. A 2020, 792, 139456. [CrossRef]
  26. Yamanaka, K.; Mori, M.; Kurosu, S.; Matsumoto, H.; Chiba, A. Ultrafine grain refinement of biomedical Co-29Cr-6Mo alloy during conventional hot-compression deformation. Metall. Mater. Trans. A 2009, 40 (8), 1980-1994. [CrossRef]
  27. İbrahim Coşkun, M.; Karahan, İ.H.; Yücel, Y.; Golden, T.D. Optimization of electrochemical step deposition for bioceramic hydroxyapatite coatings on CoCrMo implants. Surf. Coat. Technol. 2016, 301, 42-53. [CrossRef]
  28. Coşkun, M.I.; Karahan, I.H.; Yücel, Y. Optimized electrodeposition concentrations for hydroxyapatite coatings on CoCrMo biomedical alloys by computational techniques. Electrochim. Acta 2014, 150, 46-54. [CrossRef]
  29. Ghasemi-Mobarakeh, L.; Kolahreez, D.; Ramakrishna, S.; Williams, D. Key terminology in biomaterials and biocompatibility. Curr. Opin. Biomed. Eng. 2019, 10, 45-50. [CrossRef]
  30. Williams, D. Revisiting the definition of biocompatibility. Med. Device Technol. 2003, 14 (8), 10-13. PMID: 14603712.
  31. Williams, D.F. On the mechanisms of biocompatibility. Biomaterials 2008, 29, 2941-2953. [CrossRef]
  32. Barrère, F.; Mahmood, T.A.; de Groot, K.; van Blitterswijk, C.A. Advanced biomaterials for skeletal tissue regeneration: Instructive and smart functions. Mater. Sci. Eng. R 2008, 59, 38-71. [CrossRef]
  33. Moniruzzaman, M.d.; O’Neal, C.; Bhuiyan, A.; Egan, P.F. Design and Mechanical Testing of 3D Printed Hierarchical Lattices Using Biocompatible Stereolithography. Designs 2020, 4, 22. [CrossRef]
  34. Nuswantoro, N.F.; Rahandi Lubis, M.A.; Juliadmi, D.; Mardawati, E.; Antov, P.; Kristak, L.; Seng Hua, L. Bio-Based Adhesives for Orthopedic Applications: Sources, Preparation, Characterization, Challenges, and Future Perspectives. Designs 2022, 6, 96. [CrossRef]
  35. Williams, D.F. Biocompatibility pathways and mechanisms for bioactive materials: The bioactivity zone. Bioact. Mater. 2022, 10, 306-322. [CrossRef]
  36. Williams, D.F. On the nature of biomaterials. Biomaterials 2009, 30 (30), 5897-5909. [CrossRef]
  37. Cao, W.; Hench, L.L. Bioactive materials. Ceram. Int. 1996, 22 (6), 493-507. [CrossRef]
  38. Albrektsson, T.; Johansson, C. Osteoinduction, osteoconduction and osseointegration. Eur. Spine J. 2001, 10, S96-S101. [CrossRef]
  39. Andreucci, C.A.; Fonseca, E.M.M.; Jorge, R.N. Bio-Lubricant Properties Analysis of Drilling an Innovative Design of Bioactive Kinetic Screw into Bone. Designs 2023, 7, 21. [CrossRef]
  40. Shaikh, M.S.; Fareed, M.A.; Zafar, M.S. Bioactive Glass Applications in Different Periodontal Lesions: A Narrative Review. Coatings 2023, 13 (4), 716. [CrossRef]
  41. Paital, S.R.; Dahotre, N.B. Calcium phosphate coatings for bio-implant applications: Materials, performance factors, and methodologies. Mater. Sci. Eng. R 2009, 66 (1-3), 1-70. [CrossRef]
  42. Dorozhkin, S.V. Calcium orthophosphate deposits: Preparation, properties and biomedical applications. Mater. Sci. Eng. C 2015, 55, 272-326. [CrossRef]
  43. Dorozhkin, S.V. Bioceramics of calcium orthophosphates. Biomaterials 2010, 31 (7), 1465-1485. [CrossRef]
  44. LeGeros, R.Z. Calcium phosphate-based osteoinductive materials. Chem. Rev. 2008, 108 (11), 4742-4753. [CrossRef]
  45. Hench, L.L. Bioceramics. J. Am. Ceram. Soc. 1998, 81 (7), 1705-1728. [CrossRef]
  46. Navarrete-Segado, P.; Tourbin, M.; Grossin, D.; Frances, C. Tailoring hydroxyapatite suspensions by stirred bead milling. Ceram. Int. 2022, 48, 24953-24964. [CrossRef]
  47. Dorozhkin S.V. Calcium Orthophosphate (CaPO4)-Based Bioceramics: Preparation, Properties, and Applications. Coatings 2022, 12, 1380. [CrossRef]
  48. Surmenev, R.A.; Surmeneva, M.A.; Ivanova, A.A. Significance of calcium phosphate coatings for the enhancement of new bone osteogenesis - A review. Acta Biomater. 2014, 10 (2), 557-579. [CrossRef]
  49. Vallet-Regí, M.; González-Calbet, J.M. Calcium phosphates as substitution of bone tissues. Prog. Solid State Chem. 2004, 32 (1-2), 1-31. [CrossRef]
  50. Fiume, E.; Magnaterra, G.; Rahdar, A.; Verné, E.; Baino, F. Hydroxyapatite for Biomedical Applications: A Short Overview. Ceramics 2021, 4, 542–563. [CrossRef]
  51. Jeong, J.; Kim, J.H.; Shim, J.H.; Hwang, N.S.; Heo, C.Y. Bioactive calcium phosphate materials and applications in bone regeneration. Biomater. Res. 2019, 23, 4. [CrossRef]
  52. Lu, J.; Yu, H.; Chen, C. Biological properties of calcium phosphate biomaterials for bone repair: A review. RSC Advances 2018, 8, 2015-2033. [CrossRef]
  53. Drevet, R.; Benhayoune, H. Advanced Biomaterials and Coatings. Coatings 2022, 12, 965. [CrossRef]
  54. McCabe, A.; Pickford, M.; Shawcross J. The History, Technical Specifications and Efficacy of Plasma Spray Coatings Applied to Joint Replacement Prostheses. Reconstr. Rev. 2016, 6 (4), 19-26. [CrossRef]
  55. Moseke, C.; Gbureck, U. Tetracalcium phosphate: Synthesis, properties and biomedical applications. Acta Biomater. 2010, 6 (10), 3815-3823. [CrossRef]
  56. Qin, T.; Xu, Y. Fe-reinforced TTCP biocermet prepared via laser melting: Microstructure, mechanical properties and bioactivity. Ceram. Int. 2021, 47 (12), 17652-17661. [CrossRef]
  57. Mandal, S.; Meininger, S.; Gbureck, U.; Basu, B. 3D powder printed tetracalcium phosphate scaffold with phytic acid binder: Fabrication, microstructure and in situ X-Ray tomography analysis of compressive failure. J. Mater. Sci. Mater. Med. 2018, 29, 29. [CrossRef]
  58. LeGeros, R.Z. Properties of Osteoconductive Biomaterials: Calcium Phosphates. Clin. Orthop. Relat. Res. 2002, 395, 81-98. [CrossRef]
  59. Hench, L.L. Bioceramics: From Concept to Clinic. J. Am. Ceram. Soc. 1991, 74 (7), 1487-1510. [CrossRef]
  60. Szcześ, A.; Hołysz, L.; Chibowski, E. Synthesis of hydroxyapatite for biomedical applications. Adv. Colloid Interface Sci. 2017, 249, 321-330. [CrossRef]
  61. Carrodeguas, R.G.; De Aza, S. a-Tricalcium phosphate: Synthesis, properties and biomedical applications. Acta Biomaterialia 2011, 7, 3536-3546. [CrossRef]
  62. de Aza, P.N.; Luklinska, Z.B.; Mate-Sanchez de Val, J.E.; Calvo-Guirado, J.L. Biodegradation Process of a-Tricalcium Phosphate and a-Tricalcium Phosphate Solid Solution Bioceramics In Vivo: A Comparative Study. Microsc. Microanal. 2013, 19, 1350-1357. [CrossRef]
  63. Kolmas, J.; Kaflak, A.; Zima, A.; Ślósarczyk, A. Alpha-tricalcium phosphate synthesized by two different routes: Structural and spectroscopic characterization. Ceramics International 2015, 41, 5727-5733. [CrossRef]
  64. Bohner, M.; Le Gars Santoni, B.; Döbelin, N. β-tricalcium phosphate for bone substitution: Synthesis and properties. Acta Biomater. 2020, 113, 23-41. [CrossRef]
  65. Chaair, H.; Labjar, H.; Britel, O. Synthesis of b-tricalcium phosphate. Morphologie 2017, 101, 120-124. [CrossRef]
  66. Drevet, R.; Fauré, J.; Sayen, S.; Marle-Spiess, M., El Btaouri, H.; Benhayoune, H. Electrodeposition of biphasic calcium phosphate coatings with improved dissolution properties. Mater. Chem. Phys. 2019, 236, 121797. [CrossRef]
  67. Drouet, C. Apatite formation: Why it may not work as planned, and how to conclusively identify apatite compounds. BioMed Res. Int. 2013, 490946. [CrossRef]
  68. Vallet-Regí, M.; Rodriguez-Lorenzo, L.M.; Salinas, A.J. Synthesis and characterisation of calcium deficient apatite. Solid State Ionics 1997, 101-103, 1279-1285. [CrossRef]
  69. Hutchens, S.A.; Benson, R.S.; Evans, B.R.; O’Neill, H.M.; Rawn, C.J. Biomimetic synthesis of calcium-deficient hydroxyapatite in a natural hydrogel. Biomaterials 2006, 27, 4661-4670. [CrossRef]
  70. Teterina, A.Y.; Smirnov, I.V.; Fadeeva, I.S.; Fadeev, R.S.; Smirnova, P.V.; Minaychev, V.V.; Kobyakova, M.I.; Fedotov, A.Y.; Barinov, S.M.; Komlev, V.S. Octacalcium Phosphate for Bone Tissue Engineering: Synthesis, Modification, and In Vitro Biocompatibility Assessment. Int. J. Mol. Sci. 2021, 22, 12747. [CrossRef]
  71. Suzuki, O.; Hamai, R.; Sakai, S. The material design of octacalcium phosphate bone substitute: Increased dissolution and osteogenecity. Acta Biomaterialia 2023, 158, 1-11. [CrossRef]
  72. Kovrlija, I.; Locs, J.; Loca, D. Octacalcium phosphate: Innovative vehicle for the local biologically active substance delivery in bone regeneration. Acta Biomaterialia 2021, 135, 27-47. [CrossRef]
  73. Vasant, S.R.; Joshi, M.J. A review on calcium pyrophosphate and other related phosphate nano bio-materials and their applications. Rev. Adv. Mater. Sci. 2017, 49, 44-57.
  74. Yan, Y.; Wolke, J.G.C.; De Ruijter, A. ; Yubao, L.; Jansen, J.A. Growth behavior of rat bone marrow cells on RF magnetron sputtered hydroxyapatite and dicalcium pyrophosphate coatings. J. Biomed. Mater. Res. A 2006, 78A (1), 42-49. [CrossRef]
  75. Golubchikov, D.; Safronova, T.V.; Nemygina, E.; Shatalova, T.B.; Tikhomirova, I.N.; Roslyakov, I.V.; Khayrutdinova, D.; Platonov, V.; Boytsova, O.; Kaimonov, M.; Firsov, D.A.; Lyssenko, K.A. Powder Synthesized from Aqueous Solution of Calcium Nitrate and Mixed-Anionic Solution of Orthophosphate and Silicate Anions for Bioceramics Production. Coatings 2023, 13, 374. [CrossRef]
  76. Zhou, H.; Yang, L.; Gbureck, U.; Bhaduri, S.B.; Sikder, P. Monetite, an important calcium phosphate compound-Its synthesis, properties and applications in orthopedics. Acta Biomaterialia 2021, 127, 41-55. [CrossRef]
  77. Prado Da Silva, M.H.; Lima, J.H.C.; Soares, G.A.; Elias, C.N.; de Andrade, M.C.; Best, S.M.; Gibson, I.R. Transformation of monetite to hydroxyapatite in bioactive coatings on titanium. Surf. Coat. Technol. 2001, 137, 270-276. [CrossRef]
  78. Ling, L.; Xin-bo, X.; Jun, M.; Xin-ye, N.; Xie-rong, Z.; Sial, M.A.Z.G.; Dazhu, C. Post-hydrothermal treatment of hydrothermal electrodeposited CaHPO4 on C/C composites in sodium silicate-containing solution at various temperatures. Ceram. Int. 2019, 45, 5894-5903. [CrossRef]
  79. Tamimi, F.; Sheikh, Z.; Barralet, J. Dicalcium phosphate cements: Brushite and monetite. Acta Biomaterialia 2012, 8 (2), 474-487. [CrossRef]
  80. Türk, T.; Altınsoy, İ.; ÇelebiEfe, G.; Ipek, M.; Özacar, M.; Bindal, C. Biomimetric coating of monophasic brushite on Ti6Al4V in new m-5xSBF. Surf. Coat. Technol. 2018, 351, 1-10. [CrossRef]
  81. Lee, D.W.; Shin, M.C.; Kim, Y.N.; Oh, J.M. Brushite ceramic coatings for dental brace brackets fabricated via aerosol deposition. Ceram. Int. 2017, 43 (1), 1044-1051. [CrossRef]
  82. Su, Y.; Cockerill, I.; Zheng, Y.; Tang, L.; Qin, Y.X.; Zhu, D. Biofunctionalization of metallic implants by calcium phosphate coatings. Bioact. Mater. 2019, 4, 196-206. [CrossRef]
  83. Eliaz, N.; Metoki, N. Calcium phosphate bioceramics: A review of their history, structure, properties, coating technologies and biomedical applications. Materials 2017, 10 (4), 334. [CrossRef]
  84. Dorozhkin, S.V.; Calcium orthophosphates (CaPO4): Occurrence and properties. Prog. Biomater. 2016, 5 (1), 9-70. [CrossRef]
  85. Huan, Z.; Chang, J. Novel bioactive composite bone cements based on the b-tricalcium phosphate–monocalcium phosphate monohydrate composite cement system. Acta Biomaterialia 2019, 5, 1253-1264. [CrossRef]
  86. Dorozhkin, S.V.; A detailed history of calcium orthophosphates from 1770s till 1950. Mater. Sci. Eng. C 2013, 33, 3085-3110. [CrossRef]
  87. Bermúdez, O.; Boltong, M.G.; Driessens, F.C.M.; Planell, J.A. Optimization of a calcium orthophosphate cement formulation occurring in the combination of monocalcium phosphate monohydrate with calcium oxide. J. Mater. Sci. Mater. Med. 1994, 5, 67-71. [CrossRef]
  88. Ducheyne, P.; Qiu. Q. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999, 20, 2287-2303. [CrossRef]
  89. Kokubo, T.; Takadama, H.; How useful is SBF in predicting in vivo bone bioactivity? Biomaterials 2006, 27, 2907-2915. [CrossRef]
  90. Hoppe, A.; Güldal, N.S.; Boccaccini, A.R. A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials 2011, 32 (11), 2757-2774. [CrossRef]
  91. Bohner, M.; Lemaitre, J.; Can bioactivity be tested in vitro with SBF solution? Biomaterials 2009, 30 (12), 2175-2179. [CrossRef]
  92. Ho-Shui-Ling, A.; Bolander, J.; Rustom, L.E.; Wagoner Johnson, A.; Luyten, F.P.; Picart, C. Bone regeneration strategies: Engineered scaffolds, bioactive molecules and stem cells current stage and future perspectives. Biomaterials 2018, 180, 143-162. [CrossRef]
  93. Sun, L.; Berndt, C.C.; Gross, K.A.; Kucuk, A. Material Fundamentals and Clinical Performance of Plasma-Sprayed Hydroxyapatite Coatings: A Review. J. Biomed. Mater. Res. 2001, 58 (5), 570-592. [CrossRef]
  94. Gross, K.A.; Walsh, W.; Swarts, E. Analysis of retrieved hydroxyapatite-coated hip prostheses. J. Therm. Spray Technol. 2004, 13 (2), 190-199. [CrossRef]
  95. Wang, M. Composite coatings for implants and tissue engineering scaffolds. In Biomedical Composites, 1st ed.; Ambrosio, L., Eds.; Woodhead Publishing Series in Biomaterials: Cambridge, England, 2010; Part 2, Chapter 6, pp. 127-177. [CrossRef]
  96. Heimann, R.B. Plasma-Sprayed Hydroxylapatite-Based Coatings: Chemical, Mechanical, Microstructural, and Biomedical Properties. J. Therm. Spray Technol. 2016, 25 (5), 827-850. [CrossRef]
  97. Heimann, R.B. On the self-affine fractal geometry of plasma-sprayed surfaces. J. Therm. Spray Technol. 2011, 20 (4), 898-908. [CrossRef]
  98. Chambard, M.; Marsan, O.; Charvillat, C.; Grossin, D.; Fort, P.; Rey, C.; Gitzhofer, F.; Bertrand, G. Effect of the deposition route on the microstructure of plasma-sprayed hydroxyapatite coatings. Surf. Coat. Technol. 2019, 371, 68-77. [CrossRef]
  99. Heimann, R.B. Thermal spraying of biomaterials. Surf. Coat. Technol. 2006, 201 (5), 2012-2019. [CrossRef]
  100. Heimann, R.B. Structural Changes of Hydroxylapatite during Plasma Spraying: Raman and NMR Spectroscopy Results. Coatings 2021, 11, 987. [CrossRef]
  101. Heimann, R.B. Functional plasma-sprayed hydroxylapatite coatings for medical application: Clinical performance requirements and key property enhancement. J. Vac. Sci. Technol. A 2021, 39 (5), 050801. [CrossRef]
  102. Mohseni, E.; Zalnezhad, E.; Bushroa, A.R.; Comparative investigation on the adhesion of hydroxyapatite coating on Ti–6Al–4V implant: A review paper. Int. J. Adhes. Adhes. 2014, 48, 238-257. [CrossRef]
  103. Meek, J.M. A theory of spark discharge. Phys. Rev. 1940, 57 (8), 722-728. [CrossRef]
  104. Boyle, W.S.; Kisliuk, P. Departure from Paschen’s law of breakdown in gases. Phys. Rev. 1955, 97 (2), 255-259. [CrossRef]
  105. Bonafos, C.; Khomenkhova, L.; Gourbilleau, F.; Talbot, E.; Slaoui, A.; Carrada, M.; Schamm-Chardon, S.; Dimitrakis, P.; Normand, P. Nano-composite MOx materials for NVMs. In Metal Oxides for Non-volatile Memory, 1st ed.; Dimitrakis, P., Valov, I., Tappertzhofen, S., Eds.; Elsevier Science: Amsterdam, Netherlands, 2022; Chapter 7, pp. 201-244. [CrossRef]
  106. Surmenev, R.A.; Ivanova, A.A.; Epple, M.; Pichugin, V.F.; Surmeneva, M.A. Physical principles of radio-frequency magnetron sputter deposition of calcium-phosphate-based coating with tailored properties. Surf. Coat. Technol. 2021, 413, 127098. [CrossRef]
  107. Ivanova, A.A.; Surmeneva, M.A.; Tyurin, A.I.; Surmenev, R.A. Correlation between structural and mechanical properties of RF magnetron sputter deposited hydroxyapatite coating. Mater. Charact. 2018, 142, 261-269. [CrossRef]
  108. Nelea, V.; Morosanu, C.; Iliescu, M. Mihailescu, I.N. Microstructure and mechanical properties of hydroxyapatite thin films grown by RF magnetron sputtering. Surf. Coat. Technol. 2003, 173 (2-3), 315-322. [CrossRef]
  109. Safavi, M.S.; Surmeneva, M.A.; Surmenev, R.A.; Khalil-Allafi, J. RF-magnetron sputter deposited hydroxyapatite-based composite & multilayer coatings: A systematic review from mechanical, corrosion, and biological points of view. Ceram. Int. 2021, 47 (3), 3031-3053. [CrossRef]
  110. Chernozem, R.V.; Surmeneva, M.A.; Krause, B.; Baumbach, T.; Ignatov, V.P.; Tyurin, A.I.; Loza, K.; Epple, M.; Surmenev, R.A. Hybrid biocomposites based on titania nanotubes and a hydroxyapatite coating deposited by RF-magnetron sputtering: Surface topography, structure, and mechanical properties. Appl. Surf. Sci. 2017, 426, 229-237. [CrossRef]
  111. Surmeneva, M.A.; Ivanova, A.A.; Tian, Q.; Pittman, R.; Jiang, W.; Lin, J.; Liu, H.H.; Surmenev, R.A. Bone marrow derived mesenchymal stem cell response to the RF magnetron sputter deposited hydroxyapatite coating on AZ91 magnesium alloy. Mater. Chem. Phys. 2019, 221, 89-98. [CrossRef]
  112. Garcia-Sanz, F.J.; Mayor, M.B.; Arias, J.L.; Pou, J.; Leon, B.; Perez-Amor, M. Hydroxyapatite coatings: A comparative study between plasma-spray and pulsed laser deposition techniques. J. Mater. Sci. Mater. Med. 1997, 8, 861-865. [CrossRef]
  113. Koch, C.F.; Johnson, S.; Kumar, D.; Jelinek, M.; Chrisey, D.B.; Doraiswamy, A.; Jin, C.; Narayan, R.J.; Mihailescu, I.N. Pulsed laser deposition of hydroxyapatite thin films. Mater. Sci. Eng. C 2007, 27 (2-3), 484-494. [CrossRef]
  114. Popescu-Pelin, G.; Sima, F.; Sima, L.E.; Mihailescu, C.N.; Luculescu, C.; Iordache, I.; Socol, M.; Socol, G.; Mihailescu, I.N. Hydroxyapatite thin films grown by pulsed laser deposition and matrix assisted pulsed laser evaporation: Comparative study. Appl. Surf. Sci. 2017, 418 (B), 580-588. [CrossRef]
  115. Cutroneo, M.; Havranek, V.; Flaks, J.; Malinsky, P.; Torrisi, L. Pulsed Laser Deposition and Laser-Induced Backward Transfer to Modify Polydimethylsiloxane. Coatings 2021, 11, 1521. [CrossRef]
  116. Nishikawa, H.; Hasegawa, T.; Miyake, A.; Tashiro, Y.; Hashimoto, Y.; Blank, D.H.A.; Rijnders, G. Relationship between the Ca/P ratio of hydroxyapatite thin films and the spatial energy distribution of the ablation laser in pulsed laser deposition. Mater. Lett. 2016, 165, 95-98. [CrossRef]
  117. González-Estrada, O.A.; Pertuz Comas, A.D.; Ospina, R. Characterization of hydroxyapatite coatings produced by pulsed-laser deposition on additive manufacturing Ti6Al4V ELI. Thin solid films 2022, 763, 139592. [CrossRef]
  118. Duta, L.; Popescu, A.C. Current status on pulsed laser deposition of coatings from animal-origin calcium phosphate sources. Coatings 2019, 9 (5), 335. [CrossRef]
  119. Saallah, S.; Lenggoro, I.W. Nanoparticles Carrying Biological Molecules: Recent Advances and Applications. KONA Powder Part. J. 2018, 35, 89-111. [CrossRef]
  120. Leeuwenburgh, S.; Wolke, J.; Schoonman, J.; Jansen, J. Electrostatic spray deposition (ESD) of calcium phosphate coatings. J. Biomed. Mater. Res. A 2003, 66, 330-334. [CrossRef]
  121. Leeuwenburgh, S.C.G.; Wolke, J.G.C.; Siebers, M.C.; Schoonman, J.; Jansen, J.A. In vitro and in vivo reactivity of porous, electrosprayed calcium phosphate coatings. Biomaterials 2006, 27 (18), 3368-3378. [CrossRef]
  122. Müller, V.; Pagnier, T.; Tadier, S.; Gremillard, L.; Jobbagy, M.; Djurado, E. Design of advanced one-step hydroxyapatite coatings for biomedical applications using the electrostatic spray deposition. Appl. Surf. Sci. 2021, 541, 148462. [CrossRef]
  123. Huang, J.; Jayasinghe, S.N.; Best, S.M.; Edirisinghe, M.J.; Brooks, R.A.; Bonfield, W. Electrospraying of a nano-hydroxyapatite suspension. J. Mater. Sci. 2004, 39, 1029-1032. [CrossRef]
  124. Matsuura, T.; Maruyama, T. Calcium phosphate-polymer hybrid microparticles having functionalized surfaces prepared by a coaxially electrospray technique. Colloids Surf. A Physicochem. Eng. Asp. 2017, 526, 64-69. [CrossRef]
  125. Boccaccini, A.R.; Keim, S.; Ma, R.; Li, Y.; Zhitomirsky, I. Electrophoretic deposition of biomaterials. J. Royal Soc. Interface 2010, 7 (5), S581-S613. [CrossRef]
  126. Corni, I.; Ryan, M.P.; Boccaccini, A.R. Electrophoretic deposition: From traditional ceramics to nanotechnology. J. Eur. Ceram. Soc. 2008, 28 (7), 1353-1367. [CrossRef]
  127. Boccaccini, A.R.; Zhitomirsky, I. Application of electrophoretic and electrolytic deposition techniques in ceramics processing. Curr. Opin. Solid State Mater. Sci. 2002, 6 (3), 251-260. [CrossRef]
  128. Besra, L.; Liu, M. A review on fundamentals and applications of electrophoretic deposition (EPD). Prog. Mater. Sci. 2007, 52(1), 1-61. [CrossRef]
  129. Drevet, R.; Ben Jaber, N.; Fauré, J.; Tara, A.; Ben Cheikh Larbi, A.; Benhayoune, H. Electrophoretic deposition (EPD) of Nano-hydroxyapatite coatings with improved mechanical properties on prosthetic Ti6Al4V substrates. Surf. Coat. Technol. 2016, 301, 94-99. [CrossRef]
  130. Azzouz, I.; Faure, J.; Khlifi, K.; Cheikh Larbi, A.; Benhayoune, H. Electrophoretic Deposition of 45S5 Bioglass® Coatings on the Ti6Al4V Prosthetic Alloy with Improved Mechanical Properties. Coatings 2020, 10, 1192. [CrossRef]
  131. Akhtar, M.A.; Hadzhieva, Z.; Dlouhý, I.; Boccaccini, A.R. Electrophoretic Deposition and Characterization of Functional Coatings Based on an Antibacterial Gallium (III)-Chitosan Complex. Coatings 2020, 10, 483. [CrossRef]
  132. Virk, R.S.; Rehman, M.A.U.; Munawar, M.A.; Schubert, D.W.; Goldmann, W.H.; Dusza, J.; Boccaccini, A.R. Curcumin-Containing Orthopedic Implant Coatings Deposited on Poly-Ether-Ether-Ketone/Bioactive Glass/Hexagonal Boron Nitride Layers by Electrophoretic Deposition. Coatings 2019, 9, 572. [CrossRef]
  133. Bartmański, M.; Pawłowski, Ł.; Strugała, G.; Mielewczyk-Gryń, A.; Zieliński, A. Properties of nanohydroxyapatite coatings doped with nanocopper, obtained by electrophoretic deposition on Ti13Zr13Nb alloy. Materials 2019, 12 (22), 3741. [CrossRef]
  134. Sakar, P.; Nicholson, P.S. Electrophoretic deposition (EPD): Mechanisms, kinetics and application to ceramics. J. Am. Ceram. Soc. 1996, 79(8), 1987-2002. [CrossRef]
  135. Ozhukil Kollath, V.; Chen, Q.; Closset, R.; Luyten, L.; Traina, K.; Mullens, S.; Boccaccini, A.R.; Cloots, R. AC vs. DC electrophoretic deposition of hydroxyapatite on titanium. J. Eur. Ceram. Soc. 2013, 33(13-14), 2715-2721. [CrossRef]
  136. Azzouz, I.; Khlifi, K.; Faure, J.; Dhiflaoui, H.; Larbi, A.B.C.; Benhayoune, H. Mechanical behavior and corrosion resistance of sol-gel derived 45S5 bioactive glass coating on Ti6Al4V synthesized by electrophoretic deposition. J. Mech. Behav. Biomed. Mater. 2022, 134,105352. [CrossRef]
  137. Shirkhanzadeh, M. Bioactive calcium phosphate coatings prepared by electrodeposition, J. Mater. Sci. Lett. 1991, 10 (23), 1415-1417. [CrossRef]
  138. Shirkhanzadeh, M. Calcium phosphate coatings prepared by electrocrystallization from aqueous electrolytes. J. Mater. Sci. – Mater. Med. 1995, 6 (2), 90-93. [CrossRef]
  139. Drevet, R.; Benhayoune, H. Electrochemical Deposition of Calcium Phosphate Coatings on a Prosthetic Titanium Alloy Substrate. In Calcium Phosphate: Structure, synthesis, properties and applications; Heimann, R.B.; Nova Science Publishers, Inc., Hauppauge, New York, USA, 2012, pp. 231-252. ISBN: 978-162257299-1.
  140. Drevet, R.; Benhayoune, H. Electrodeposition of Calcium Phosphate Coatings on Metallic Substrates for Bone Implant Applications: A Review. Coatings 2022, 12 (4), 539. [CrossRef]
  141. Redepenning, J.; McIsaac, J.P. Electrocrystallization of Brushite Coatings on Prosthetic Alloys. Chem. Mater. 1990, 2 (6), 625-627. [CrossRef]
  142. Zhitomirsky, I. Cathodic electrodeposition of ceramic and organoceramic materials. Fundamental aspects. Adv. Colloid Interface Sci. 2002, 97 (1-3), 279-317. [CrossRef]
  143. Eliaz, N.; Eliyahu, M. Electrochemical processes of nucleation and growth of hydroxyapatite on titanium supported by real-time electrochemical atomic force microscopy. J. Biomed. Mater. Res. A 2007, 80 (3), 621-634. [CrossRef]
  144. Eliaz, N.; Sridhar, T.M. Electrocrystallization of hydroxyapatite and its dependence on solution conditions. Cryst. Growth Des. 2008, 8 (11), 3965-3977. [CrossRef]
  145. Kuo, M.C.; Yen, S.K. The process of electrochemical deposited hydroxyapatite coatings on biomedical titanium at room temperature. Mater. Sci. Eng. C 2002, 20 (1-2), 153-160. [CrossRef]
  146. Zielinski, A.; Bartmanski, M. Electrodeposited biocoatings, their properties and fabrication technologies: A review. Coatings 2020, 10 (8), 782. [CrossRef]
  147. Lin, S.; LeGeros, R.Z.; LeGeros, J.P. Adherent octacalcium phosphate coating on titanium alloy using modulated electrochemical deposition method. J. Biomed. Mater. Res. A 2003, 66 (4), 819-828. [CrossRef]
  148. Furko, M.; Balázsi, C. Calcium phosphate based bioactive ceramic layers on implant materials preparation, properties, and biological performance. Coatings 2020, 10 (9), 823. [CrossRef]
  149. Drevet, R.; Lemelle, A.; Untereiner, V.; Manfait, M.; Sockalingum, G.D.; Benhayoune, H. Morphological modifications of electrodeposited calcium phosphate coatings under amino acids effect. Appl. Surf. Sci. 2013, 268, 343-348. [CrossRef]
  150. Drevet, R.; Viteaux, A.; Maurin, J.C.; Benhayoune, H. Human osteoblast-like cells response to pulsed electrodeposited calcium phosphate coatings. RSC Advances 2013, 3, 11148-11154. [CrossRef]
  151. Vidal, E.; Buxadera-Palomero, J.; Pierre, C.; Manero, J.M.; Ginebra, M.P.; Cazalbou, S.; Combes, C.; Rupérez, E.; Rodríguez, D. Single-step pulsed electrodeposition of calcium phosphate coatings on titanium for drug delivery. Surf. Coat. Technol. 2019, 358, 266-275. [CrossRef]
  152. Jimenez-Garcia, F.N.; Giraldo-Torres, L.R.; Restrepo-Parra, E. Electrochemically deposited calcium phosphate coatings using a potentiostat of in-house design and implementation. Mater. Res. 2021, 25 (5), e20210098. [CrossRef]
  153. Vidal, E.; Guillem-Marti, J.; Ginebra, M.-P.; Combes, C.; Rupérez, E.; Rodriguez, D. Multifunctional homogeneous calcium phosphate coatings: Toward antibacterial and cell adhesive titanium scaffolds. Surf. Coat. Technol. 2021, 405, 126557. [CrossRef]
  154. Safavi, M.S.; Walsh, F.C.; Surmeneva, M.A.; Surmenev, R.A.; Khalil-Allafi, J. Electrodeposited hydroxyapatite-based biocoatings: Recent progress and future challenges. Coatings 2021, 11 (1), 110. [CrossRef]
  155. Gao, A.; Hang, R.; Bai, L.; Tang, B.; Chu, P.K. Electrochemical surface engineering of titanium-based alloys for biomedical application. Electrochim. Acta 2018, 271, 699-718. [CrossRef]
  156. Ben Jaber, N.; Drevet, R.; Fauré, J.; Demangel, C.; Potiron, S.; Tara, A.; Ben Cheikh Larbi, A.; Benhayoune, H. A new process for the thermal treatment of calcium phosphate coatings electrodeposited on Ti6Al4V substrate. Adv. Eng. Mater. 2015, 17 (11), 1608-1615. [CrossRef]
  157. Degli Esposti, L.; Markovic, S.; Ignjatovic, N.; Panseri, S.; Montesi, M.; Adamiano, A.; Fosca, M.; Rau, J.V.; Uskoković, V.; Iafisco, M. Thermal crystallization of amorphous calcium phosphate combined with citrate and fluoride doping: A novel route to produce hydroxyapatite bioceramics. J. Mater. Chem. B 2021, 9, 4832-4845. [CrossRef]
  158. Gerk, S.A.; Golovanova, O.A.; Odazhiu, V.N. Structural, Morphological, and Resorption Properties of Carbonate Hydroxyapatite Prepared in the Presence of Glycine. Inorg. Mater. 2018, 54 (3), 305-314. [CrossRef]
  159. Hu, Q.; Tan, Z.; Liu, Y.; Tao, J.; Cai, Y. ; Zhang, M. ; Pan, H. ; Xu, X.; Tang, R. Effect of crystallinity of calcium phosphate nanoparticles on adhesion, proliferation, and differentiation of bone marrow mesenchymal stem cells. J. Mater. Chem. 2007, 17, 4690-4698. [CrossRef]
  160. Implants for surgery - Hydroxyapatite - Part 2: Thermally sprayed coatings of hydroxyapatite 2018, ISO 13779-2.
  161. Raynaud, S.; Champion, E.; Bernache-Assollant, D. Calcium phosphate apatites with variable Ca/P atomic ratio II. Calcination and sintering. Biomaterials 2002, 23 (4), 1073-1080. [CrossRef]
  162. Destainville, A.; Champion, E.; Bernache-Assollant, D.; Laborde, E. Synthesis, characterization and thermal behavior of apatitic tricalcium phosphate. Mater. Chem. Phys. 2003, 80 (1), 269-277. [CrossRef]
  163. Implants for surgery - Hydroxyapatite - Part 3: Analyse chimique et caractérisation du rapport de cristallinité et de la pureté de phase 2018, ISO 13779-3.
  164. Ducheyne, P.; Qiu, Q. Bioactive ceramics: The effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999, 20 (23-24), 2287-2303. [CrossRef]
  165. Iwamoto, T.; Hieda, Y.; Kogai, Y. Effect of hydroxyapatite surface morphology on cell adhesion. Mater. Sci. Eng. C 2016, 69, 1263-1267. [CrossRef]
  166. Drevet R.; Fauré, J.; Benhayoune, H. Structural and morphological study of electrodeposited calcium phosphate materials submitted to thermal treatment. Mater. Lett. 2017, 209, 27-31. [CrossRef]
  167. Liu, S.; Li, H.; Zhang, L.; Yin, X.; Guo, Y. In simulated body fluid performance of polymorphic apatite coatings synthesized by pulsed electrodeposition. Mater. Sci. Eng. C 2017, 79, 100-107. [CrossRef]
  168. Lee, W.K.; Lee, S.M.; Kim, H.M. Effect of surface morphology of calcium phosphate on osteoblast-like HOS cell responses. J. Ind. Eng. Chem. 2009, 15 (5), 677-682. [CrossRef]
  169. Cairns, M.L.; Meenan, B.J.; Burke, G.A.; Boyd, A.R. Influence of surface topography on osteoblast response to fibronectin coated calcium phosphate thin films. Colloids Surf. B 2010, 78 (2), 283-290. [CrossRef]
  170. Pujari-Palmer, S.; Chen, S.; Rubino, S.; Weng, H.; Xia, W.; Engqvist, H.; Tang, L.; Ott, M.K. In vivo and in vitro evaluation of hydroxyapatite nanoparticle morphology on the acute inflammatory response. Biomaterials 2016, 90, 1-11. [CrossRef]
  171. Chen, S.; Guo, Y.; Liu, R.; Wu, S.; Fang, J.; Huang, B.; Li, Z.; Chen, Z.; Chen, Z. Tuning surface properties of bone biomaterials to manipulate osteoblastic cell adhesion and the signaling pathways for the enhancement of early osseointegration. Colloids Surf. B 2018, 164, 58-69. [CrossRef]
  172. Khlusov, I.A.; Dekhtyar, Y.; Sharkeev, Y.P.; Pichugin, V.F.; Khlusova, M.Y.; Polyaka, N.; Tyulkin, F.; Vendinya, V.; Legostaeva, E.V.; Litvinova, L.S.; Shupletsova, V.V.; Khaziakhmatova, O.G.; Yurova, K.A.; Prosolov, K.A. Nanoscale electrical potential and roughness of a calcium phosphate surface promotes the osteogenic phenotype of stromal cells. Materials 2018, 11 (6), 978. [CrossRef]
  173. Deligianni, D.D.; Katsala, N.D.; Koutsoukos, P.G.; Missirlis, Y.F. Effect of surface roughness of hydroxyapatite on human bone marrow cell adhesion, proliferation, differentiation and detachment strength. Biomaterials 2000, 22 (1), 87-96. [CrossRef]
  174. Anselme, K.; Bigerelle, M. On the Relation Between Surface Roughness of Metallic Substrates and Adhesion of Human Primary Bone Cells. Scanning 2014, 36, 11-20. [CrossRef]
  175. Giljean, S.; Bigerelle, M.; Anselme, K. Roughness Statistical Influence on Cell Adhesion Using Profilometry and Multiscale Analysis. Scanning 2014, 36, 2-10. [CrossRef]
  176. Adeleke, S.A.; Ramesh, S.; Bushroa, A.R.; Ching, Y.C.; Sopyan, I.; Maleque, M.A.; Krishnasamy, S.; Chandran, H.; Misran, H., Sutharsini, U. The properties of hydroxyapatite ceramic coatings produced by plasma electrolytic oxidation. Ceram. Int. 2018, 44 (2), 1802-1811. [CrossRef]
  177. Maidaniuc, A.; Miculescu, F.; Voicu, S.I.; Andronescu, C.; Miculescu, M.; Matei, M.; Mocanu, A.C.; Pencea, I.; Csaki, I.; Machedon-Pisu, T.; Ciocan, L.T. Induced wettability and surface-volume correlation of composition for bovine bone derived hydroxyapatite particles. Appl. Surf. Sci. 2018, 438, 158-166. [CrossRef]
  178. Paital, S.R.; Dahotre, N.B. Wettability and kinetics of hydroxyapatite precipitation on a laser-textured Ca-P bioceramic coating. Acta Biomaterialia 2009, 5 (7), 2763-2772. [CrossRef]
  179. Bodhak, S.; Bose, S.; Bandyopadhyay, A. Role of surface charge and wettability on early stage mineralization and bone cell–materials interactions of polarized hydroxyapatite. Acta Biomaterialia 2009, 5 (6), 2178-2188. [CrossRef]
  180. Doshi, B.; Sillanpää, M.; Kalliola, S. A review of bio-based materials for oil spill treatment. Water Res. 2018, 135, 262-277. [CrossRef]
  181. Thian, E.S.; Ahmad, Z.; Huang, J.; Edirisinghe, M.J.; Jayasinghe S.N.; Ireland, D.C.; Brooks, R.A.; Rushton, N.; Bonfield, W.; Best, S.M. The role of surface wettability and surface charge of electrosprayed nanoapatites on the behaviour of osteoblasts. Acta Biomaterialia 2010, 6 (3), 750-755. [CrossRef]
  182. Aronov, D.; Rosen, R.; Ron, E.Z.; Rosenman, G. Tunable hydroxyapatite wettability: Effect on adhesion of biological molecules. Process Biochem. 2006, 41 (12), 2367-2372. [CrossRef]
  183. Fornell, J.; Feng, Y.P.; Pellicer, E.; Suriñach, S.; Baró, M.D.; Sort, J. Mechanical behaviour of brushite and hydroxyapatite coatings electrodeposited on newly developed FeMnSiPd alloys. J. Alloys Compd. 2017, 729, 231-239. [CrossRef]
  184. Fathyunes, L.; Khalil-Allafi, J.; Moosavifar, M. Development of graphene oxide/calcium phosphate coating by pulse electrodeposition on anodized titanium: Biocorrosion and mechanical behavior. J. Mech. Behav. Biomed. Mater. 2019, 90, 575-586. [CrossRef]
  185. Singh, S.; Prakash, C.; Singh, H. Deposition of HA-TiO2 by plasma spray on β-phase Ti-35Nb-7Ta-5Zr alloy for hip stem: Characterization, mechanical properties, corrosion, and in-vitro bioactivity. Surf. Coat. Technol. 2020, 398, 126072. [CrossRef]
  186. Drevet, R.; Fauré, J.; Benhayoune, H. Thermal Treatment Optimization of Electrodeposited Hydroxyapatite Coatings on Ti6Al4V Substrate. Adv. Eng. Mater. 2012, 14 (6), 377-382. [CrossRef]
  187. Harun, W.S.W.; Asri, R.I.M.; Alias, J.; Zulkifli, F.H.; Ghani, S.A.C.; Shariffuddin, J.H.M. A comprehensive review of hydroxyapatite-based coatings adhesion on metallic biomaterials. Ceram. Int. 2018, 44, 1250-1268. [CrossRef]
  188. Implants for surgery - Hydroxyapatite - Part 4: Determination of coating adhesion strength 2018, ISO 13779-4.
  189. Uskoković, V. Ion-doped hydroxyapatite: An impasse or the road to follow? Ceram. Int. 2020, 46, 11443-11465. [CrossRef]
  190. Furko, M.; Balázsi, C. Morphological, chemical, and biological investigation of ionic substituted, pulse current deposited calcium phosphate coatings. Materials 2020, 13 (20), 4690. [CrossRef]
  191. Ungureanu, E.; Vranceanu, D.M.; Vladescu, A.; Parau, A.C.; Tarcolea, M.; Cotrut, C.M. Effect of doping element and electrolyte’s ph on the properties of hydroxyapatite coatings obtained by pulsed galvanostatic technique. Coatings 2021, 11 (12), 1522. [CrossRef]
  192. Panda, S.; Biswas, C.K.; Paul, S. A comprehensive review on the preparation and application of calcium hydroxyapatite: A special focus on atomic doping methods for bone tissue engineering. Ceram. Int. 2021, 47 (20), 28122-28144. [CrossRef]
  193. Schatkoski, V.M.; Larissa do Amaral Montanheiro, T.; Canuto de Menezes, B.R.; Pereira, R.M.; Rodrigues, K.F.; Ribas, R.G.; Morais da Silva, D.; Thim, G.P. Current advances concerning the most cited metal ions doped bioceramics and silicate-based bioactive glasses for bone tissue engineering. Ceram. Int. 2021, 47 (3), 2999-3012. [CrossRef]
  194. Boanini, E.; Gazzano, M.; Bigi, A. Ionic substitutions in calcium phosphates synthesized at low temperature. Acta Biomater. 2010, 6 (6), 1882-1894. [CrossRef]
  195. Bigi, A.; Boanini, E.; Gazzano, M. Ion Substitution in Biological and Synthetic Apatites. Biomineralization and Biomaterials: Fundamentals and Applications 2016, pp. 235-266. [CrossRef]
  196. Wang, W.; Yeung, K.W.K. Bone grafts and biomaterials substitutes for bone defect repair: A review. Bioact. Mater. 2017, 2, 224-247. [CrossRef]
  197. Panda, S.; Kumar Biswas, C.; Paul, S. A comprehensive review on the preparation and application of calcium hydroxyapatite: A special focus on atomic doping methods for bone tissue engineering. Ceram. Int. 2021, 47, 28122-28144. [CrossRef]
  198. Arcos, D.; Vallet-Regi, M. Substituted hydroxyapatite coatings of bone implants. J. Mater. Chem. B 2020, 8, 1781-1800. [CrossRef]
  199. Ratnayake, J.T.B.; Mucalo, M.; Dias, G.J. Substituted hydroxyapatites for bone regeneration: A review of current trends. J. Biomed. Mater. Res. B 2017, 105B, 1285-1299. [CrossRef]
  200. Dubnika, A.; Loca, D.; Rudovica, V.; Parekh, M.B.; Berzina-Cimdina, L. Functionalized Silver Doped Hydroxyapatite Scaffolds for Controlled Simultaneous Ion and Drug Delivery. Ceram. Int. 2017, 43, 3698-3705. [CrossRef]
  201. Chen, K.; Ustriyana, P.; Moore, F.; Sahai, N. Biological Response of and Blood Plasma Protein Adsorption on Silver-Doped Hydroxyapatite. ACS Biomater. Sci. Eng. 2019, 5, 561−571. [CrossRef]
  202. Mokabber, T.; Cao, H.T.; Norouzi, N.; van Rijn, P.; Pei, Y.T. Antimicrobial Electrodeposited Silver-Containing Calcium Phosphate Coatings. ACS Appl. Mater. Interfaces 2020, 12, 5531-5541. [CrossRef]
  203. Wiesmann, H.P.; Plate, U.; Zierold, K.; Höhling, H.J. Potassium is Involved in Apatite Biomineralization. J. Dent. Res. 1998, 77 (8), 1654-1657. [CrossRef]
  204. Kannan, S.; Ventura, J.M.G.; Ferreira, J.M.F. Synthesis and thermal stability of potassium substituted hydroxyapatites and hydroxyapatite/b-tricalcium phosphate mixtures. Ceram. Int. 2007, 33, 1489-1494. [CrossRef]
  205. Kumar, M.; Xie, J.; Chittur, K.; Riley, C. Transformation of modified brushite to hydroxyapatite in aqueous solution: Effects of potassium substitution. Biomaterials 1999, 20, 1389-1399. [CrossRef]
  206. Kaygili, O.; Keser, S.; Ates, T.; Yakuphanoglu, F. Synthesis and characterization of lithium calcium phosphate ceramics. Ceram. Int. 2013, 39, 7779-7785. [CrossRef]
  207. Pan, C.; Chen, L.; Wu, R.; Shan, H.; Zhou, Z.; Lin, Y.; Yu, X.; Yan, L.; Wu, C. Lithium-containing biomaterials inhibit osteoclastogenesis of macrophages in vitro and osteolysis in vivo. J. Mater. Chem. B 2018, 6, 8115-8126. [CrossRef]
  208. Wang, Y.; Yang, X.; Gu, Z.; Qin, H.; Li, L.; Liu, J.; Yu, X. In vitro study on the degradation of lithium-doped hydroxyapatite for bone tissue engineering scaffold. Mater. Sci. Eng. C 2016, 66, 185-192. [CrossRef]
  209. Li, H.; Zhao, X.; Cao, S.; Li, K.; Chen, M.; Xu, Z.; Lu, J.; Zhang, L. Na-doped hydroxyapatite coating on carbon/carbon composites: Preparation, in vitro bioactivity and biocompatibility. Appl. Surf. Sci. 2012, 263, 163-173. [CrossRef]
  210. Kannan, S.; Ventura, J.M.G.; Lemos, A.F.; Barba, A.; Ferreira, J.M.F. Effect of sodium addition on the preparation of hydroxyapatites and biphasic ceramics. Ceram. Int. 2008, 34 (1), 7-13. [CrossRef]
  211. Sang Cho, J.; Um, S.H.; Su Yoo, D.; Chung, Y.C.; Chung, S.H.; Lee, J.C.; Rhee, S.H. Enhanced osteoconductivity of sodium-substituted hydroxyapatite by system instability. J. Biomed. Mater. Res. B 2014, 102 (5), 1046-1062. [CrossRef]
  212. Tang, C.-M.; Fan, F.-Y.; Ke, Y.-C.; Lin, W.-C. Effects of electrode plate annealing treatment and the addition of hydrogen peroxide on improving the degradation of cobalt hydroxyapatite for bone repair. Mater. Chem. Phys. 2021, 259, 123962. [CrossRef]
  213. Lin, W.C.; Chuang, C.C.; Wang, P.T.; Tang, C.M. A comparative study on the direct and pulsed current electrodeposition of cobalt-substituted hydroxyapatite for magnetic resonance imaging application. Mater. 2018, 12 (1), 116. [CrossRef]
  214. Drevet, R.; Zhukova, Y.; Dubinskiy, S.; Kazakbiev, A.; Naumenko, V.; Abakumov, M.; Fauré, J.; Benhayoune, H.; Prokoshkin, S. Electrodeposition of cobalt-substituted calcium phosphate coatings on Ti22Nb6Zr alloy for bone implant applications. J. Alloys Compd. 2019, 793, 576-582. [CrossRef]
  215. Grass, G.; Rensing, C.; Solioz, M. Metallic copper as an antimicrobial surface. Appl. Environ. Microbiol. 2011, 77 (5), 1541-1547. [CrossRef]
  216. Wolf-Brandstetter, C.; Oswald, S.; Bierbaum, S.; Wiesmann, H.-P.; Scharnweber, D. Influence of pulse ratio on codeposition of copper species with calcium phosphate coatings on titanium by means of electrochemically assisted deposition. J. Biomed. Mater. Res. B 2014, 102 (1), 160-172. [CrossRef]
  217. Prosolov, K.A.; Lastovka, V.V.; Khimich, M.A.; Chebodaeva, V.V.; Khlusov, I.A.; Sharkeev, Y.P. RF Magnetron Sputtering of Substituted Hydroxyapatite for Deposition of Biocoatings. Materials 2022, 15, 6828. [CrossRef]
  218. Farzadi, A.; Bakhshi, F.; Solati-Hashjin, M.; Asadi-Eydivand, M.; Osman, N.A.A. Magnesium incorporated hydroxyapatite: Synthesis and structural properties characterization. Ceram. Int. 2014, 40 (4), 6021-6029. [CrossRef]
  219. Cacciotti, I.; Bianco, A.; Lombardi, M.; Montanaro, L. Mg-substituted hydroxyapatite nanopowders: Synthesis, thermal stability and sintering behaviour. J. Eur. Ceram. Soc. 2009, 29 (14), 2969-2978. [CrossRef]
  220. Vranceanu, D.M.; Ionescu, I.C.; Ungureanu, E.; Cojocaru, M.O.; Vladescu, A.; Cotrut, C.M. Magnesium doped hydroxyapatite-based coatings obtained by pulsed galvanostatic electrochemical deposition with adjustable electrochemical behavior. Coatings 2020, 10, 727. [CrossRef]
  221. Huang, Y.; Qiao, H.; Nian, X.; Zhang, X.; Zhang, X.; Song, G.; Xu, Z.; Zhang, H.; Han, S. Improving the bioactivity and corrosion resistance properties of electrodeposited hydroxyapatite coating by dual doping of bivalent strontium and manganese ion. Surf. Coat. Technol. 2016, 291, 205-215. [CrossRef]
  222. Huang, Y.; Ding, Q.; Han, S.; Yan, Y.; Pang, X. Characterisation, corrosion resistance and in vitro bioactivity of manganese-doped hydroxyapatite films electrodeposited on titanium. J. Mater. Sci. – Mater. Med. 2013, 24, 1853-1864. [CrossRef]
  223. Fadeeva, I.V.; Kalita, V.I.; Komlev, D.I.; Radiuk, A.A.; Fomin, A.S.; Davidova, G.A.; Nadezhda K. Fursova, N.K.; Murzakhanov, F.F.; Gafurov, M.R.; Fosca, M.; Antoniac, I.V.; Barinov, S.M., Rau, J.V. In Vitro Properties of Manganese-Substituted Tricalcium Phosphate Coatings for Titanium Biomedical Implants Deposited by Arc Plasma. Mater. 2020, 13 (19), 4411. [CrossRef]
  224. Pilmane, M.; Salma-Ancane, K.; Loca, D.; Locs, J.; Berzina-Cimdina, L. Strontium and strontium ranelate: Historical review of some of their functions. Mater. Sci. Eng. C 2017, 78, 1222-1230. [CrossRef]
  225. Boanini, E.; Torricelli, P.; Fini, M.; Bigi, A. Osteopenic bone cell response to strontium-substituted hydroxyapatite. J. Mater. Sci. – Mater. Med. 2011, 22 (9), 2079-2088. [CrossRef]
  226. Drevet, R.; Benhayoune, H. Pulsed electrodeposition for the synthesis of strontium-substituted calcium phosphate coatings with improved dissolution properties. Mater. Sci. Eng. C 2013, 33, 4260-4265. [CrossRef]
  227. Capuccini, C.; Torricelli, P.; Sima, F.; Boanini, E.; Ristoscu, C.; Bracci, B.; Socol, G.; Fini, M.; Mihailescu, I.N.; Bigi, A. Strontium-substituted hydroxyapatite coatings synthesized by pulsed-laser deposition: In vitro osteoblast and osteoclast response. Acta Biomaterialia 2008, 4 (6), 1885-1893. [CrossRef]
  228. Tang, Y.; Chappell, H.F.; Dove, M.T.; Reeder, R.J.; Lee, Y.J. Zinc incorporation into hydroxylapatite. Biomaterials 2009, 30 (15), 2864-2872. [CrossRef]
  229. Huang, Y.; Zhang, X.; Mao, H.; Li, T.; Zhao, R.; Yan, Y.; Pang, X. Osteoblastic cell responses and antibacterial efficacy of Cu/Zn co-substituted hydroxyapatite coatings on pure titanium using electrodeposition method. RSC Advances 2015, 5 (22), 17076-17086. [CrossRef]
  230. Furko, M.; Jiang, Y.; Wilkins, T.; Balázsi, C. Development and characterization of silver and zinc doped bioceramic layer on metallic implant materials for orthopedic application. Ceram. Int. 2016, 42, 4924-4931. [CrossRef]
  231. El Khouri, A.; Zegzouti, A.; Elaatmani, M.; Capitelli, F. Bismuth-substituted hydroxyapatite ceramics synthesis: Morphological, structural, vibrational and dielectric properties. Inorg. Chem. Commun. 2019, 110, 107568. [CrossRef]
  232. Ciobanu, G.; Bargan, A.M.; Luca, C. New Bismuth-Substituted Hydroxyapatite Nanoparticles for Bone Tissue Engineering. JOM 2015, 67 (11), 2534-2542. [CrossRef]
  233. Ahmed, M.K.; Mansour, S.F.; Mostafa, M.S.; Darwesh, R.; El-dek, S.I. Structural, mechanical and thermal features of Bi and Sr co-substituted hydroxyapatite. J. Mater. Sci. 2019, 54 (3), 1977-1991. [CrossRef]
  234. Lin, Y.; Yang, Z.; Cheng, J. Preparation, Characterization and Antibacterial Property of Cerium Substituted Hydroxyapatite Nanoparticles. J. Rare Earths 2007, 25 (4), 452-456. [CrossRef]
  235. Feng, Z.; Liao, Y.; Ye, M. Synthesis and structure of cerium-substituted hydroxyapatite. J. Mater. Sci. – Mater. Med. 2005, 16 (5), 417-421. [CrossRef]
  236. Ciobanu, G.; Harja, M. Cerium-doped hydroxyapatite/collagen coatings on titanium for bone implants. Ceram. Int. 2019, 45 (2), 2852-2857. [CrossRef]
  237. Nisar, A.; Iqbal, S.; Atiq Ur Rehman, M.; Mahmood, A.; Younas, M.; Hussain, S.Z.; Tayyaba, Q.; shah, A. Study of physico-mechanical and electrical properties of cerium doped hydroxyapatite for biomedical applications. Mater. Chem. Phys. 2023, 299, 127511. [CrossRef]
  238. Alshemary, A.Z.; Akram, M.; Goh, Y.F.; Abdul Kadir, M.R.; Abdolahi, A. Hussain, R. Structural characterization, optical properties and in vitro bioactivity of mesoporous erbium-doped hydroxyapatite. J. Alloys Compds. 2015, 645, 478-486. [CrossRef]
  239. Neacsu, I.A.; Stoica, A.E.; Vasile, B.S.; Andronescu, E. Luminescent hydroxyapatite doped with rare earth elements for biomedical applications. Nanomaterials 2019, 9 (2), 239. [CrossRef]
  240. Pham, V.H.; Van, H.N.; Tam, P.D.; Ha, H.N.T. A novel 1540 nm light emission from erbium doped hydroxyapatite/β-tricalcium phosphate through co-precipitation method. Mater. Lett. 2016, 167, 145-147. [CrossRef]
  241. Yang, P.; Quan, Z.; Li, C.; Kang, X.; Lian, H. Lin, J. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier. Biomaterials 2008, 29 (32), 4341-4347. [CrossRef]
  242. Al-Kattan, A.; Santran, V.; Dufour, P.; Dexpert-Ghys, J.; Drouet, C. Novel contributions on luminescent apatite-based colloids intended for medical imaging. J. Biomater. Appl. 2014, 28 (5), 697-707. [CrossRef]
  243. Graeve, O.A.; Kanakala, R.; Madadi, A.; Williams, B.C.; Glass, K.C. Luminescence variations in hydroxyapatites doped with Eu2+ and Eu3+ ions. Biomaterials 2010, 31 (15), 4259-4267. [CrossRef]
  244. Singh, R.K.; Srivastava, M.; Prasad, N.K.; Awasthi, S.; Dhayalan, A.; Kannan, S. Iron doped β-Tricalcium phosphate: Synthesis, characterization, hyperthermia effect, biocompatibility and mechanical evaluation. Mater. Sci. Eng. C 2017, 78, 715-726. [CrossRef]
  245. Singh, R.K.; Srivastava, M.; Prasad, N.K.; Shetty, P.H.; Kannan, S. Hyperthermia effect and antibacterial efficacy of Fe3+ /Co2+ co-substitutions in β-Ca3(PO4)2 for bone cancer and defect therapy. J. Biomed. Mater. Res. B 2018, 106 (3), 1317-1328. [CrossRef]
  246. Predoi, D.; Iconaru, S.L.; Ciobanu, S.C.; Predoi, S.A.; Nuton, N.; Megier, C.; Beuran, M. Development of Iron-Doped Hydroxyapatite Coatings. Coatings 2021, 11 (2), 186. [CrossRef]
  247. Melnikov, P.; Teixeira, A.R.; Malzac, A.; Coelho, M.d.B. Gallium-containing hydroxyapatite for potential use in orthopedics. Mater. Chem. Phys. 2009, 117 (1), 86-90. [CrossRef]
  248. Korbas, M.; Rokita, E.; Meyer-Klaucke, W.; Ryczek, J. Bone tissue incorporates in vitro gallium with a local structure similar to gallium-doped brushite. J. Biol. Inorg. Chem. 2004, 9 (1), 67-76. [CrossRef]
  249. Mosina, M.; Siverino, C.; Stipniece, L.; Sceglovs, A.; Vasiljevs, R.; Moriarty, T.F.; Locs, J. Gallium-Doped Hydroxyapatite Shows Antibacterial Activity against Pseudomonas aeruginosa without Affecting Cell Metabolic Activity. J. Funct. Biomater. 2023, 14, 51. [CrossRef]
  250. Paduraru, A.V.; Oprea, O.; Musuc, A.M.; Vasile, B.S.; Iordache, F.; Andronescu, E. Influence of Terbium Ions and Their Concentration on the Photoluminescence Properties of Hydroxyapatite for Biomedical Applications. Nanomaterials 2021, 11, 2442. [CrossRef]
  251. Jiménez-Flores, Y.; Suárez-Quezada, M.; Rojas-Trigos, J.B.; Lartundo-Rojas, J.B.; Suárez, V., Mantilla, A. Characterization of Tb-doped hydroxyapatite for biomedical applications: Optical properties and energy band gap determination. J. Mater. Sci. 2017, 52, 9990-10000. [CrossRef]
  252. Demnati, I.; Grossin, D.; Combes, C.; Parco, M.; Braceras, I; Rey, C. A comparative physico-chemical study of chlorapatite and hydroxyapatite: From powders to plasma sprayed thin coatings. Biomed. Mater. 2012, 7 (5), 054101. [CrossRef]
  253. Navarrete-Segado, P.; Frances, C; Tourbin, M.; Tenailleau, C.; Duployer, B.; Grossin, D. Powder bed selective laser process (sintering/melting) applied to tailored calcium phosphate-based powders. Addit. Manuf. 2022, 50, 102542. [CrossRef]
  254. Ito, A.; Otsuka, Y.; Takeuchi, M.; Tanaka, H. Mechanochemical synthesis of chloroapatite and its characterization by powder X-ray diffractometory and attenuated total reflection-infrared spectroscopy. Colloid. Polym. Sci. 2017, 295, 2011-2018. [CrossRef]
  255. Merry, J.C.; Gibson, I.R.; Best, S.M.; Bonfield, W. Synthesis and characterization of carbonate hydroxyapatite. J. Mater. Sci. Mater. Med. 1998, 9, 779-783. [CrossRef]
  256. Zhang, L.; Li, H.; Li, K.; Song, Q.; Fu, Q.; Zhang, Y.; Liu, S. Electrodeposition of carbonate-containing hydroxyapatite on carbon nanotubes/carbon fibers hybrid materials for tissue engineering application. Ceram. Int. 2015, 41 (3), 4930-4935. [CrossRef]
  257. Landi, E.; Celotti, G.; Logroscino, G.; Tampieri, A. Carbonated hydroxyapatite as bone substitute. J. Europ. Ceram. Soc. 2003, 23 (15), 2931-2937. [CrossRef]
  258. Ge, X.; Zhao, J.; Lu, X.; Li, Z.; Wang, K.; Ren, F.; Wang, M.; Wang, Q.; Qian, B. Controllable phase transformation of fluoridated calcium phosphate ultrathin coatings for biomedical applications. J. Alloys Compd. 2020, 847, 155920. [CrossRef]
  259. Wang, J.; Chao, Y.; Wan, Q.; Zhu, Z.; Yu, H. Fluoridated hydroxyapatite coatings on titanium obtained by electrochemical deposition. Acta Biomater. 2009, 5 (5), 1798-1807. [CrossRef]
  260. Sun, J.; Wu, T.; Fan, Q.; Hu, Q.; Shi, B. Comparative study of hydroxyapatite, fluor-hydroxyapatite and Si-substituted hydroxyapatite nanoparticles on osteogenic, osteoclastic and antibacterial ability. RSC Adv. 2019, 9, 16106-16118. [CrossRef]
  261. Wang, Y.; Wang, J.; Hao, H.; Cai, M.; Wang, S.; Ma, J.; Li, Y. Mao, C.; Zhang, S. In Vitro and in Vivo Mechanism of Bone Tumor Inhibition by Selenium-Doped Bone Mineral Nanoparticles. ACS Nano 2016, 10 (11), 9927-9937. [CrossRef]
  262. Rodríguez-Valencia, C.; López-Álvarez, M.; Cochón-Cores, B.; Pereiro, I.; Serra, J.; González, P. Novel selenium-doped hydroxyapatite coatings for biomedical applications. J. Biomed. Mater. Res. A 2013, 101 (3), 853-861. [CrossRef]
  263. Tan, H.W.; Mo, H.Y.; Lau, A.T.Y.; Xu, Y.M. Selenium species: Current status and potentials in cancer prevention and therapy. Int. J. Mol. Sci. 2019, 20 (1), 75. [CrossRef]
  264. Casarrubios, L.; Gómez-Cerezo, N.; Sánchez-Salcedo, S.; Feito, M.J.; Serrano, M.C.; Saiz-Pardo, M.; Ortega, L.; de Pablo, D.; Díaz-Güemes, I.; Fernández-Tomé, B.; Enciso, S.; Sánchez-Margallo, F.M.; Portolés, M.T.; Arcos, D.; Vallet-Regí, M. Silicon substituted hydroxyapatite/VEGF scaffolds stimulate bone regeneration in osteoporotic sheep. Acta Biomaterialia 2020, 101, 544-553. [CrossRef]
  265. Aboudzadeh, N.; Dehghanian, C.; Shokrgozar, M.A. Effect of electrodeposition parameters and substrate on morphology of Si-HA coating. Surf. Coat. Technol. 2019, 375, 341-351. [CrossRef]
  266. Dehghanian, C.; Aboudzadeh, N.; Shokrgozar, M.A. Characterization of silicon-substituted nano hydroxyapatite coating on magnesium alloy for biomaterial application. Mater. Chem. Phys. 2018, 203, 27-33. [CrossRef]
  267. Graziani, G.; Boi, M.; Bianchi, M. A Review on Ionic Substitutions in Hydroxyapatite Thin Films: Towards Complete Biomimetism. Coatings 2018, 8, 269. [CrossRef]
  268. Mumith, A.; Cheong, V.S.; Fromme, P.; Coathup, M.J.; Blunn, G.W. The effect of strontium and silicon substituted hydroxyapatite electrochemical coatings on bone ingrowth and osseointegration of selective laser sintered porous metal implants. PLoS ONE 2020, 15 (1), e0227232. [CrossRef]
  269. Robinson, L.; Salma-Ancane, K.; Stipniece, L.; Meenan, B.J.; Boyd, A.R. The deposition of strontium and zinc Co-substituted hydroxyapatite coatings. J. Mater. Sci. – Mater. Med. 2017, 28 (3), 51. [CrossRef]
  270. Wolf-Brandstetter, C.; Beutner, R; Hess, R.; Bierbaum, S.; Wagner, K.; Scharnweber, D.; Gbureck, U.; Moseke, C. Multifunctional calcium phosphate based coatings on titanium implants with integrated trace elements. Biomed. Mater. 2020, 15, 025006. [CrossRef]
  271. Liu, S.j.; Li, H.j.; Zhang, L.l.; Feng, L.; Yao, P. Strontium and magnesium substituted dicalcium phosphate dehydrate coating for carbon/carbon composites prepared by pulsed electrodeposition. Appl. Surf. Sci. 2015, 359, 288-292. [CrossRef]
  272. Kolmas, J.; Groszyk, E.; Kwiatkowska-Rózycka, D. Substituted hydroxyapatites with antibacterial properties. BioMed Res. Int. 2014, 178123. [CrossRef]
  273. Garbo, C.; Locs, J.; D’este, M.; Demazeau, G.; Mocanu, A.; Roman, C.; Horovitz, O.; Tomoaia-Cotisel, M. Advanced Mg, Zn, Sr, Si multi-substituted hydroxyapatites for bone regeneration. Int. J. Nanomed. 2020, 15, 1037-1058. [CrossRef]
  274. Bracci, B.; Torricelli, P.; Panzavolta, S.; Boanini, E.; Giardino, R.; Bigi, A. Effect of Mg2+, Sr2+, and Mn2+ on the chemico-physical and in vitro biological properties of calcium phosphate biomimetic coatings. J. Inorg. Biochem. 2009, 103 (12), 1666-1674. [CrossRef]
  275. Furko, M.; Jiang, Y.; Wilkins, T.A.; Balázsi, C. Electrochemical and morphological investigation of silver and zinc modified calcium phosphate bioceramic coatings on metallic implant materials. Mater. Sci. Eng. C 2016, 62, 249-259. [CrossRef]
  276. Furko, M.; May, Z.; Havasi, V.; Kónya, Z.; Grünewald, A.; Detsch, R.; Boccaccini, A.R.; Balázsi, C. Pulse electrodeposition and characterization of non-continuous, multi-element-doped hydroxyapatite bioceramic coatings. J. Solid State Electrochem. 2018, 22, 555-566. [CrossRef]
  277. Furko, M.; Della Bella, E.; Fini, M.; Balázsi, C. Corrosion and biocompatibility examination of multi-element modified calcium phosphate bioceramic layers. Mater. Sci. Eng. C 2019, 95, 381-388. [CrossRef]
  278. Huang, Y.; Ding, Q.; Pang, X.; Han, S.; Yan, Y. Corrosion behavior and biocompatibility of strontium and fluorine co-doped electrodeposited hydroxyapatite coatings. Appl. Surf. Sci. 2013, 282, 456-462. [CrossRef]
  279. Bir, F.; Khireddine, H.; Mekhalif, Z.; Bonnamy, S. Pulsed electrodeposition of Ag+ doped prosthetic Fluorohydroxyapatite coatings on stainless steel substrates. Mater. Sci. Eng. C 2021, 118, 111325. [CrossRef]
  280. Vo, T.H.; Le, T.D.; Pham, T.N.; Nguyen, T.T.; Nguyen, T.P.; Dinh, T.M.T. Electrodeposition and characterization of hydroxyapatite coatings doped by Sr2+, Mg2+, Na+ and F− on 316L stainless steel. Adv. Nat. Sci. Nanosci. Nanotechnol. 2018, 9, 045001. [CrossRef]
  281. Chambard, M.; Remache, D.; Balcaen, Y.; Dalverny, O.; Alexis, J.; Siadous, R.; Bareille, R.; Catros, S.; Fort, P.; Grossin, D.; Gitzhofer, F.; Bertrand, G. Effect of silver and strontium incorporation route on hydroxyapatite coatings elaborated by rf-SPS. Materialia 2020, 12, 100809. [CrossRef]
Preprints 73404 g001
Figure 1. Schematic diagram of the events at the interface between a bioactive calcium phosphate coating (solid) and the surrounding physiological environment: (1) partial dissolution of the calcium phosphate coating; (2) precipitation from the solution; (3) ion exchange and structural rearrangement at the bioceramic/tissue interface; (4) interdiffusion from the surface boundary layer into the bioceramics; (5) solution-mediated effects on cellular activity; (6) deposition of either the mineral phase (a) or the organic phase (b) without integration into the bioceramic surface; (7) deposition with integration into the bioceramics; (8) chemotaxis to the bioceramic surface; (9) cell attachment and proliferation; (10) cell differentiation; (11) extracellular matrix formation. Reprinted with permission from Ref. [88].
Figure 1. Schematic diagram of the events at the interface between a bioactive calcium phosphate coating (solid) and the surrounding physiological environment: (1) partial dissolution of the calcium phosphate coating; (2) precipitation from the solution; (3) ion exchange and structural rearrangement at the bioceramic/tissue interface; (4) interdiffusion from the surface boundary layer into the bioceramics; (5) solution-mediated effects on cellular activity; (6) deposition of either the mineral phase (a) or the organic phase (b) without integration into the bioceramic surface; (7) deposition with integration into the bioceramics; (8) chemotaxis to the bioceramic surface; (9) cell attachment and proliferation; (10) cell differentiation; (11) extracellular matrix formation. Reprinted with permission from Ref. [88].
Preprints 73404 g001
Preprints 73404 g002
Figure 2. Schematic diagram of plasma spray deposition of calcium phosphate coatings. Reprinted with permission from Ref. [95].
Figure 2. Schematic diagram of plasma spray deposition of calcium phosphate coatings. Reprinted with permission from Ref. [95].
Preprints 73404 g002
Preprints 73404 g003
Figure 3. Schematic diagram of magnetron sputtering deposition of calcium phosphate coatings. Reprinted with permission from Ref. [105].
Figure 3. Schematic diagram of magnetron sputtering deposition of calcium phosphate coatings. Reprinted with permission from Ref. [105].
Preprints 73404 g003
Preprints 73404 g004
Figure 4. Schematic diagram of pulsed laser deposition of calcium phosphate coatings. Reprinted with permission from Ref. [115].
Figure 4. Schematic diagram of pulsed laser deposition of calcium phosphate coatings. Reprinted with permission from Ref. [115].
Preprints 73404 g004
Preprints 73404 g005
Figure 5. Schematic diagram of electrospray deposition of calcium phosphate coatings. Reprinted and adapted with permission from Ref. [119].
Figure 5. Schematic diagram of electrospray deposition of calcium phosphate coatings. Reprinted and adapted with permission from Ref. [119].
Preprints 73404 g005
Preprints 73404 g006
Figure 6. Schematic diagram of the droplets on their way from the tip of the needle to the substrate during the electrospray deposition process. Reprinted and adapted with permission from Ref. [119].
Figure 6. Schematic diagram of the droplets on their way from the tip of the needle to the substrate during the electrospray deposition process. Reprinted and adapted with permission from Ref. [119].
Preprints 73404 g006
Preprints 73404 g007
Figure 7. Model of the electric double layer of a negative particle in a solution. Reprinted with permission from Ref. [128].
Figure 7. Model of the electric double layer of a negative particle in a solution. Reprinted with permission from Ref. [128].
Preprints 73404 g007
Preprints 73404 g008
Figure 8. Schematic diagram of (a) cathodic EPD and (b) anodic EPD. Reprinted with permission from Ref. [128].
Figure 8. Schematic diagram of (a) cathodic EPD and (b) anodic EPD. Reprinted with permission from Ref. [128].
Preprints 73404 g008
Preprints 73404 g009
Figure 9. EPD coating formation model: (a) size reduction of the double layer, (b) coagulation of particles. Reprinted with permission from Ref. [134].
Figure 9. EPD coating formation model: (a) size reduction of the double layer, (b) coagulation of particles. Reprinted with permission from Ref. [134].
Preprints 73404 g009
Preprints 73404 g010
Figure 10. Schematic diagram of electrodeposition of calcium phosphate coatings. Reprinted with permission from Ref. [140].
Figure 10. Schematic diagram of electrodeposition of calcium phosphate coatings. Reprinted with permission from Ref. [140].
Preprints 73404 g010
Preprints 73404 g011
Figure 11. Schematic diagram of the cathode-electrolyte interface during electrodeposition. Reprinted with permission from Ref. [140].
Figure 11. Schematic diagram of the cathode-electrolyte interface during electrodeposition. Reprinted with permission from Ref. [140].
Preprints 73404 g011
Preprints 73404 g012
Figure 12. Surface wettability as a function of the contact angle measurement. Reprinted with permission from Ref. [180].
Figure 12. Surface wettability as a function of the contact angle measurement. Reprinted with permission from Ref. [180].
Preprints 73404 g012
Preprints 73404 g013
Figure 13. Schematic diagram of the standardized measurement of tensile adhesion. Reprinted with permission from Ref. [140].
Figure 13. Schematic diagram of the standardized measurement of tensile adhesion. Reprinted with permission from Ref. [140].
Preprints 73404 g013
Table 1. Calcium phosphates described in the literature as coatings for bone implants.
Table 1. Calcium phosphates described in the literature as coatings for bone implants.
calcium phosphate abbreviation chemical formulae (Ca/P)at. solubility [-log Ks] references
tetracalcium phosphate TTCP C a 4 ( P O 4 ) 2 O 2 2.00 38.0-44.0 [55,56,57]
hydroxyapatite HAP C a 10 ( P O 4 ) 6 O H 2 1.67 116.8 [58,59,60]
α-tricalcium phosphate α-TCP α − C a 3 ( P O 4 ) 2 1.50 25.5 [61,62,63]
β-tricalcium phosphate β-TCP β − C a 3 ( P O 4 ) 2 1.50 28.9 [64,65,66]
calcium-deficient apatite Ca-def apatite C a 10 − x ( H P O 4 ) x ( P O 4 ) 6 − x ( O H ) 2 − x
with 0 < x < 2		 1.34-1.66 85.1 [67,68,69]
octacalcium phosphate OCP C a 8 ( H P O 4 ) 2 ( P O 4 ) 4 · 5 H 2 O 1.33 96.6 [70,71,72]
calcium pyrophosphate CPP C a 2 P 2 O 7 1.00 18.5 [73,74,75]
dicalcium phosphate anhydrous, aka monetite DCPA C a H P O 4 1.00 6.9 [76,77,78]
dicalcium phosphate dihydrate, aka brushite DCPD C a H P O 4 · 2 H 2 O 1.00 6.6 [79,80,81]
monocalcium phosphate anhydrous MCPA C a ( H 2 P O 4 ) 2 0.50 1.1 [82,83,84]
monocalcium phosphate monohydrate MCPM C a ( H 2 P O 4 ) 2 · H 2 O 0.50 1.1 [85,86,87]
Table 2. Ions used as substituents in calcium phosphate coatings.
Table 2. Ions used as substituents in calcium phosphate coatings.
Ions Biological / Chemical effect References
monovalent cations
A g + antibacterial activity [200,201,202]
K + osteogenesis [203,204,205]
L i + osteogenesis [206,207,208]
N a + osteogenesis [209,210,211]
divalent cations
C o 2 + angiogenesis [212,213,214]
C u 2 + antibacterial activity [215,216,217]
M g 2 + osteogenesis [218,219,220]
M n 2 + osteogenesis [221,222,223]
S r 2 + osteogenesis [224,225,226,227]
Z n 2 + osteogenesis/antibacterial/anti-inflammatory [228,229,230]
trivalent cations
B i 3 + anticancer/antibacterial [231,232,233]
C e 3 + antibacterial [234,235,236,237]
E r 3 + photoluminescence [238,239,240]
E u 3 + photoluminescence [241,242,243]
F e 3 + osteogenesis/anticancer/antibacterial [244,245,246]
G a 3 + anticancer/antibacterial [247,248,249]
T b 3 + photoluminescence [250,251]
anions
C l − osteogenesis [252,253,254]
C O 3 2 − osteogenesis [255,256,257]
F − antibacterial [258,259,260]
S e O 3 2 − / S e O 4 2 − anticancer/antibacterial [261,262,263]
S i O 4 4 − osteogenesis [264,265,266]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

facebook logotwitter logolinkedin logo
MDPI Initiatives
Important Links
Subscribe

Disclaimer

Terms of Use

Privacy Policy

© 2024 MDPI (Basel, Switzerland) unless otherwise stated